Doma (DOMA) 10-Q 10 Nov 21 2021 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Sep. 30, 2021	Nov. 08, 2021
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2021
Document Transition Report	false
Entity File Number	001-39754
Entity Registrant Name	Doma Holdings, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	84-1956909
Entity Address, Address Line One	101 Mission Street
Entity Address, Address Line Two	Suite 740
Entity Address, City or Town	San Francisco
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94105
City Area Code	650
Local Phone Number	419-3827
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding (in shares)		322,574,242
Entity Central Index Key	0001722438
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Class A common stock, par value $0.0001
Entity Information [Line Items]
Title of 12(b) Security	Common stock, par value $0.0001 per share
Trading Symbol	DOMA
Security Exchange Name	NYSE
Warrants, each whole warrant exercisable for one share at an exercise price of $11.50 per share
Entity Information [Line Items]
Title of 12(b) Security	Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 per share
Trading Symbol	DOMA.WS
Security Exchange Name	NYSE

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Assets
Cash and cash equivalents	$ 411,669	$ 111,893
Restricted cash	2,021	129
Fixed maturities
Held-to-maturity debt securities, at amortized cost	74,872	65,406
Available-for-sale debt securities, at fair value (amortized cost $7,139 at December 31, 2020)	0	8,057
Equity securities, at fair value (cost $2,000 at December 31, 2020)	0	2,119
Mortgage loans	2,920	2,980
Other invested assets	306	0
Total Investments	78,098	78,562
Receivables (net of provision for doubtful accounts of $571 at September 30, 2021 and $492 at December 31, 2020)	14,485	15,244
Prepaid expenses, deposits and other assets	22,161	7,365
Fixed assets (net of accumulated depreciation of $17,283 at September 30, 2021 and $15,065 at December 31, 2020)	35,243	21,661
Title plants	13,952	14,008
Goodwill	111,487	111,487
Trade names (net of accumulated amortization of $3,187 at December 31, 2020)	0	2,684
Total assets	689,116	363,033
Liabilities and stockholders’ equity
Accounts payable	6,651	6,626
Accrued expenses and other liabilities	50,187	33,044
Senior secured credit agreement, net of debt issuance costs and original issue discount	138,684	0
Loan from a related party	0	65,532
Liability for loss and loss adjustment expenses	78,671	69,800
Warrant liabilities	24,440	0
Sponsor Covered Shares liability	8,610	0
Total liabilities	307,243	175,002
Commitments and contingencies
Stockholders’ equity:
Common stock, 0.0001 par value; 2,000,000,000 shares authorized at September 30, 2021; 321,544,052 and 62,832,307 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively	33	1
Additional paid-in capital	530,290	266,464
Accumulated deficit	(148,450)	(79,123)
Accumulated other comprehensive income	0	686
Total stockholders’ equity	381,873	188,031
Total liabilities and stockholders’ equity	689,116	363,033
Preferred Stock Series A
Stockholders’ equity:
Preferred stock	0	1
Preferred Stock Series A-1
Stockholders’ equity:
Preferred stock	0	1
Preferred Stock Series A-2
Stockholders’ equity:
Preferred stock	0	0
Preferred Stock Series B
Stockholders’ equity:
Preferred stock	0	0
Preferred Stock Series C
Stockholders’ equity:
Preferred stock	$ 0	$ 1

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Available-for-sale debt securities, amortized cost		$ 7,139
Equity securities, fair value	$ 0	2,000
Provision for doubtful accounts	571	492
Accumulated depreciation	$ 17,283	15,065
Accumulated amortization		$ 3,187
Preferred stock, par value (in usd per share)	$ 0.0001
Preferred stock, shares authorized (in shares)	100,000,000
Preferred stock, shares issued (in shares)	0
Preferred stock, shares outstanding (in shares)	0
Common stock, par value (in usd per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	2,000,000,000
Common stock, shares issued (in shares)	321,544,052	62,832,307
Common stock, shares outstanding (in shares)	321,544,052	62,832,307
Preferred Stock Series A
Preferred stock, par value (in usd per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	0
Preferred stock, shares issued (in shares)	0	43,737,586
Preferred stock, shares outstanding (in shares)	0	43,737,586
Preferred Stock Series A-1
Preferred stock, par value (in usd per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	0
Preferred stock, shares issued (in shares)	0	48,913,906
Preferred stock, shares outstanding (in shares)	0	48,913,906
Preferred Stock Series A-2
Preferred stock, par value (in usd per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	0
Preferred stock, shares issued (in shares)	0	14,003,187
Preferred stock, shares outstanding (in shares)	0	14,003,187
Preferred Stock Series B
Preferred stock, par value (in usd per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	0
Preferred stock, shares issued (in shares)	0	15,838,828
Preferred stock, shares outstanding (in shares)	0	15,838,828
Preferred Stock Series C
Preferred stock, par value (in usd per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	0
Preferred stock, shares issued (in shares)	0	60,665,631
Preferred stock, shares outstanding (in shares)	0	60,665,631

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Revenues:
Net premiums written	[1]	$ 141,491	$ 103,587	$ 358,754	$ 246,738
Escrow, other title-related fees and other		20,452	16,742	59,092	43,298
Investment, dividend and other income		639	743	2,518	2,268
Total revenues		162,582	121,072	420,364	292,304
Expenses:
Premiums retained by Third-Party Agents	[2]	91,596	67,024	227,115	156,132
Title examination expense		5,289	4,624	15,643	11,811
Provision for claims		6,685	5,242	16,741	10,065
Personnel costs		62,410	36,197	159,829	104,652
Other operating expenses		21,693	10,210	53,038	31,136
Total operating expenses		187,673	123,297	472,366	313,796
Loss from operations		(25,091)	(2,225)	(52,002)	(21,492)
Other (expense) income:
Change in fair value of Warrant and Sponsor Covered Shares liabilities		(4,478)	0	(4,478)	0
Interest expense		(4,531)	(1,193)	(12,341)	(4,428)
Loss before income taxes		(34,100)	(3,418)	(68,821)	(25,920)
Income tax expense		(170)	(204)	(506)	(620)
Net loss		$ (34,270)	$ (3,622)	$ (69,327)	$ (26,540)
Earnings per share:
Net loss per share attributable to shareholders - basic (in usd per share)		$ (0.14)	$ (0.06)	$ (0.54)	$ (0.43)
Net loss per share attributable to shareholders - diluted (in usd per share)		$ (0.14)	$ (0.06)	$ (0.54)	$ (0.43)
Weighted average shares outstanding common stock - basic (in shares)		245,003,754	64,060,987	128,105,954	62,255,035
Weighted average shares outstanding common stock - diluted (in shares)		245,003,754	64,060,987	128,105,954	62,255,035
[1]	Net premiums written includes revenues from a related party of $30.3 million and $22.9 million during the three months ended September 30, 2021 and 2020, respectively. Net premiums written includes revenues from a related party of $81.9 million and $64.2 million during the nine months ended September 30, 2021 and 2020, respectively (see Note 11).
[2]	Premiums retained by Third-Party Agents includes expenses associated with a related party of $24.8 million and $18.4 million during the three months ended September 30, 2021 and 2020, respectively. Premiums retained by Third-Party Agents includes expenses associated with a related party of $66.6 million and $51.9 million during the nine months ended September 30, 2021 and 2020, respectively (see Note 11).

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Operations (Parenthetical) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Net premiums written	[1]	$ 141,491	$ 103,587	$ 358,754	$ 246,738
Premiums retained by agents	[2]	91,596	67,024	227,115	156,132
Lennar | Affiliated Entity
Net premiums written		30,300	22,900	81,900	64,200
Premiums retained by agents		$ 24,800	$ 18,400	$ 66,600	$ 51,900
[1]	Net premiums written includes revenues from a related party of $30.3 million and $22.9 million during the three months ended September 30, 2021 and 2020, respectively. Net premiums written includes revenues from a related party of $81.9 million and $64.2 million during the nine months ended September 30, 2021 and 2020, respectively (see Note 11).
[2]	Premiums retained by Third-Party Agents includes expenses associated with a related party of $24.8 million and $18.4 million during the three months ended September 30, 2021 and 2020, respectively. Premiums retained by Third-Party Agents includes expenses associated with a related party of $66.6 million and $51.9 million during the nine months ended September 30, 2021 and 2020, respectively (see Note 11).

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Statement of Comprehensive Income [Abstract]
Net loss	$ (34,270)	$ (3,622)	$ (69,327)	$ (26,540)
Other comprehensive income, net of tax:
Unrealized gain (loss) on available-for-sale debt securities, net of tax	0	443	(179)	(53)
Reclassification adjustment for realized gain on sale of available-for-sale debt securities, net of tax	0	0	(507)	0
Comprehensive loss	$ (34,270)	$ (3,179)	$ (70,013)	$ (26,593)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Total	Previously Reported	Revision of Prior Period, Adjustment	Common Stock	Preferred StockPreferred Stock Series A	Preferred StockPreferred Stock Series APreviously Reported	Preferred StockPreferred Stock Series ARevision of Prior Period, Adjustment	Preferred StockPreferred Stock Series A-1	Preferred StockPreferred Stock Series A-1Previously Reported	Preferred StockPreferred Stock Series A-1Revision of Prior Period, Adjustment	Preferred StockPreferred Stock Series A-2	Preferred StockPreferred Stock Series A-2Previously Reported	Preferred StockPreferred Stock Series A-2Revision of Prior Period, Adjustment	Preferred StockPreferred Stock Series B	Preferred StockPreferred Stock Series BPreviously Reported	Preferred StockPreferred Stock Series BRevision of Prior Period, Adjustment	Preferred StockPreferred Stock Series C	Preferred StockPreferred Stock Series CPreviously Reported	Preferred StockPreferred Stock Series CRevision of Prior Period, Adjustment	Common Stock	Common StockPreviously Reported	Common StockRevision of Prior Period, Adjustment	Common StockCommon Stock	Additional paid-in capital	Additional paid-in capitalPreviously Reported	Additional paid-in capitalCommon Stock	Accumulated deficit	Accumulated deficitPreviously Reported	Accumulated other comprehensive income (loss)	Accumulated other comprehensive income (loss)Previously Reported
Beginning balance (in shares) at Dec. 31, 2019					43,737,586	7,295,759	36,441,827	48,913,906	8,159,208	40,754,698	14,003,187	2,335,837	11,667,350	15,838,828	2,642,036	13,196,792	25,599,456	4,270,182	21,329,274	62,191,701	10,374,044	51,817,657
Beginning balance at Dec. 31, 2019	$ 149,345	$ 149,345	$ 0		$ 1	$ 1		$ 1	$ 1		$ 0	$ 0		$ 0	$ 0		$ 0	$ 0		$ 1	$ 1			$ 192,852	$ 192,852		$ (44,020)	$ (44,020)	$ 510	$ 510
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Series C preferred stock, net of financing costs (in shares)																	35,066,175
Issuance of Series C preferred stock, net of financing costs	70,702																$ 1							70,701
Exercise of stock options (in shares)																				378,214
Exercise of stock options	24																							24
Stock based compensation expense	308																							308
Net loss	(16,586)																										(16,586)
Other comprehensive loss	9																												9
Ending balance (in shares) at Mar. 31, 2020					43,737,586			48,913,906			14,003,187			15,838,828			60,665,631			62,569,915
Ending balance at Mar. 31, 2020	203,802				$ 1			$ 1			$ 0			$ 0			$ 1			$ 1				263,885			(60,606)		519
Beginning balance (in shares) at Dec. 31, 2019					43,737,586	7,295,759	36,441,827	48,913,906	8,159,208	40,754,698	14,003,187	2,335,837	11,667,350	15,838,828	2,642,036	13,196,792	25,599,456	4,270,182	21,329,274	62,191,701	10,374,044	51,817,657
Beginning balance at Dec. 31, 2019	149,345	149,345	0		$ 1	$ 1		$ 1	$ 1		$ 0	$ 0		$ 0	$ 0		$ 0	$ 0		$ 1	$ 1			192,852	192,852		(44,020)	(44,020)	510	510
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(26,540)
Ending balance (in shares) at Sep. 30, 2020					43,737,586			48,913,906			14,003,187			15,838,828			60,665,631			62,206,658
Ending balance at Sep. 30, 2020	194,415				$ 1			$ 1			$ 0			$ 0			$ 1			$ 1				264,514			(70,560)		457
Beginning balance (in shares) at Mar. 31, 2020					43,737,586			48,913,906			14,003,187			15,838,828			60,665,631			62,569,915
Beginning balance at Mar. 31, 2020	203,802				$ 1			$ 1			$ 0			$ 0			$ 1			$ 1				263,885			(60,606)		519
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)																				(590,309)
Exercise of stock options	27																							27
Stock based compensation expense	282																							282
Net loss	(6,332)																										(6,332)
Other comprehensive loss	(505)																												(505)
Ending balance (in shares) at Jun. 30, 2020					43,737,586			48,913,906			14,003,187			15,838,828			60,665,631			61,979,606
Ending balance at Jun. 30, 2020	197,274				$ 1			$ 1			$ 0			$ 0			$ 1			$ 1				264,194			(66,938)		14
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Legal costs associated with the issuance of Series C (in shares)																				11,696
Costs associated with issuance of stock	(50)																							(50)
Exercise of stock options (in shares)																				215,356
Exercise of stock options	15																							15
Stock based compensation expense	355																							355
Net loss	(3,622)																										(3,622)
Other comprehensive loss	443																												443
Ending balance (in shares) at Sep. 30, 2020					43,737,586			48,913,906			14,003,187			15,838,828			60,665,631			62,206,658
Ending balance at Sep. 30, 2020	194,415				$ 1			$ 1			$ 0			$ 0			$ 1			$ 1				264,514			(70,560)		457
Beginning balance (in shares) at Dec. 31, 2020					43,737,586	7,295,759	36,441,827	48,913,906	8,159,208	40,754,698	14,003,187	2,335,837	11,667,350	15,838,828	2,642,036	13,196,792	60,665,631	10,119,484	50,546,147	62,832,307	10,480,902	52,351,405
Beginning balance at Dec. 31, 2020	188,031	188,031	0		$ 1	$ 1		$ 1	$ 1		$ 0	$ 0		$ 0	$ 0		$ 1	$ 1		$ 1	$ 1			266,464	266,464		(79,123)	(79,123)	686	686
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)																				2,637,441
Exercise of stock options	1,267																							1,267
Stock based compensation expense	2,289																							2,289
Original issue discount on senior secured credit agreement	18,519																							18,519
Net loss	(11,758)																										(11,758)
Other comprehensive loss	(686)																												(686)
Ending balance (in shares) at Mar. 31, 2021					43,737,586			48,913,906			14,003,187			15,838,828			60,665,631			65,469,748
Ending balance at Mar. 31, 2021	197,662				$ 1			$ 1			$ 0			$ 0			$ 1			$ 1				288,539			(90,881)		0
Beginning balance (in shares) at Dec. 31, 2020					43,737,586	7,295,759	36,441,827	48,913,906	8,159,208	40,754,698	14,003,187	2,335,837	11,667,350	15,838,828	2,642,036	13,196,792	60,665,631	10,119,484	50,546,147	62,832,307	10,480,902	52,351,405
Beginning balance at Dec. 31, 2020	$ 188,031	$ 188,031	$ 0		$ 1	$ 1		$ 1	$ 1		$ 0	$ 0		$ 0	$ 0		$ 1	$ 1		$ 1	$ 1			266,464	$ 266,464		(79,123)	$ (79,123)	686	$ 686
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)	4,004,764
Net loss	$ (69,327)
Ending balance (in shares) at Sep. 30, 2021					0			0			0			0			0			321,544,052
Ending balance at Sep. 30, 2021	381,873				$ 0			$ 0			$ 0			$ 0			$ 0			$ 33				530,290			(148,450)		0
Beginning balance (in shares) at Mar. 31, 2021					43,737,586			48,913,906			14,003,187			15,838,828			60,665,631			65,469,748
Beginning balance at Mar. 31, 2021	197,662				$ 1			$ 1			$ 0			$ 0			$ 1			$ 1				288,539			(90,881)		0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)																				535,551
Exercise of stock options	109																							109
Stock based compensation expense	2,967																							2,967
Exercise of stock warrants (in shares)								28,870,387
Exercise of stock warrants	187																							187
Net loss	(23,299)																										(23,299)
Ending balance (in shares) at Jun. 30, 2021					43,737,586			77,784,293			14,003,187			15,838,828			60,665,631			66,005,299
Ending balance at Jun. 30, 2021	177,626				$ 1			$ 1			$ 0			$ 0			$ 1			$ 1				291,802			(114,180)		0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Costs associated with issuance of stock	(54,217)																							(54,217)
Exercise of stock options (in shares)																				82,230
Exercise of stock options	38																							38
Stock based compensation expense	3,191																							3,191
Net loss	(34,270)																										(34,270)
Conversion of stock (in shares)					(43,737,586)			(77,784,293)			(14,003,187)			(15,838,828)			(60,665,631)			212,029,525			(1,227,451)
Conversion of stock	22			$ 30,080	$ (1)			$ (1)									$ (1)			$ 21				4		$ 30,080
Issuance of common stock in connection with Business Combination and PIPE Investment (in shares)																				44,654,449
Issuance of common stock in connection with Business Combination and PIPE Investment	259,397																			$ 5				259,392
Par value change for Old Doma Common Stock	6																			$ 6
Ending balance (in shares) at Sep. 30, 2021					0			0			0			0			0			321,544,052
Ending balance at Sep. 30, 2021	$ 381,873				$ 0			$ 0			$ 0			$ 0			$ 0			$ 33				$ 530,290			$ (148,450)		$ 0

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash flow from operating activities:
Net loss	$ (69,327)	$ (26,540)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest expense - paid in kind	6,353	5,085
Depreciation and amortization	7,705	3,236
Stock-based compensation expense	8,447	945
Amortization of debt issuance costs and original issue discount	1,429	0
Provision for doubtful accounts	562	304
Deferred income taxes	377	535
Realized gain on debt securities	(908)	(141)
Net unrealized loss on equity securities	119	10
Gain on disposal of fixed assets and title plants	(11)	(281)
Accretion of discounts on held-to-maturity securities	901	369
Change in fair value of Warrant and Sponsor Covered Shares liabilities	4,478	0
Change in operating assets and liabilities:
Accounts receivable	(284)	(261)
Prepaid expenses, deposits and other assets	(14,799)	(6,166)
Accounts payable	(274)	2,658
Accrued expenses and other liabilities	13,813	472
Liability for loss and loss adjustments expenses	8,872	3,374
Net cash used in operating activities	(32,547)	(16,401)
Cash flow from investing activities:
Proceeds from sales, calls and maturities of investments: Held-to-maturity	23,514	15,394
Proceeds from sales, calls and maturities of investments: Available-for-sale	7,817	18
Proceeds from sales of investments: Equity securities	2,000	0
Proceeds from sales and principal repayments of investments: Mortgage loans	60	378
Purchases of investments: Held-to-maturity	(33,650)	(57,624)
Purchases of investments: Equity securities	0	(1,000)
Proceeds from sales of fixed assets	306	246
Purchases of fixed assets	(18,842)	(12,670)
Proceeds from sale of title plants and dividends from title plants	482	1,349
Net cash used in investing activities	(18,313)	(53,909)
Cash flow from financing activities:
Proceeds from issuance of Series C preferred stock, net of financing costs	0	70,701
Proceeds from issuance of senior secured credit agreement	150,000	0
Payments on loan from a related party	(65,532)	(28,092)
Debt issuance costs	(579)	0
Exercise of stock warrants	48	0
Exercise of stock options	1,690	92
Redemptions of redeemable common and preferred stock	(294,856)	0
Net proceeds from Business Combination and PIPE Investment	624,952	0
Payment of costs directly attributable to the issuance of common stock in connection with Business Combination and PIPE Investment	(63,195)	0
Net cash provided by financing activities	352,528	42,701
Net change in cash and cash equivalents and restricted cash	301,668	(27,609)
Cash and cash equivalents and restricted cash at the beginning period	112,022	141,668
Cash and cash equivalents and restricted cash at the end of period	413,690	114,059
Supplemental cash flow disclosures:
Cash paid for interest	5,347	1
Supplemental disclosure of non-cash investing and financing activities:
Unrealized loss on available-for-sale debt securities	(179)	(53)
Issuance of penny warrants related to the senior secured credit agreement	(18,519)	0
Warrant liabilities recognized in conjunction with the Business Combination	19,240	0
Net liabilities assumed in the Business Combination	$ 9,517	$ 0

Organization and business opera

Organization and business operations	9 Months Ended
	Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and business operations	Organization and business operations On July 28, 2021 (the “Closing Date”), Capitol Investment Corp. V (“Capitol”) consummated a business combination (the “Business Combination”) with Doma Holdings, Inc., a Delaware corporation (“Old Doma”), pursuant to the agreement and plan of merger, dated March 2, 2021, by and among Capitol, Capitol V Merger Sub, Inc., a wholly owned subsidiary of Capitol (“Merger Sub”), and Old Doma (as amended on March 18, 2021, the “Agreement”). In connection with the closing of the Business Combination, Old Doma changed its name to States Title Holding, Inc. (“States Title”), Capitol changed its name to Doma Holdings, Inc. (“Doma”) and Old Doma became a wholly owned subsidiary of Doma. Doma continues the existing business operations of Old Doma as a publicly traded company. See Note 3 for additional information on the Business Combination. Unless the context otherwise requires, references herein to “company,” “Company,” “Doma,” “we,” “us,” “our” and similar terms refer to Doma Holdings, Inc. (f/k/a Capitol Investment Corp. V) and its consolidated subsidiaries. References to “Capitol” refer to our legal predecessor company prior to the consummation of the Business Combination. References to “Old Doma” refer to Old Doma prior to the Business Combination and to States Title, the wholly owned subsidiary of Doma, upon the consummation of the Business Combination. Headquartered in San Francisco, California, Doma is a real estate technology company that is architecting the future of real estate transactions. Using machine intelligence and our proprietary technology solutions, we are creating a vastly more simple, efficient, and affordable real estate closing experience for current and prospective homeowners, lenders, title agents and real estate professionals. We are licensed to underwrite title insurance in 39 states and the District of Columbia. Old Doma was initially formed as a wholly-owned subsidiary of States Title Inc. (“Legacy States Title”) to combine the operations of Legacy States Title and the retail agency and title insurance underwriting business (the “Acquired Business”) of North American Title Group, LLC (“NATG”), a subsidiary of Lennar Corporation (“Lennar”). We completed the acquisition of the Acquired Business on January 7, 2019, which we refer hereinafter as the “North American Title Acquisition.” Old Doma survived the North American Title Acquisition as the parent company and now wholly owns the businesses operated by Legacy States Title and the Acquired Business. We conduct our operations through two reportable segments, (1) Distribution and (2) Underwriting. See further discussion in Note 7 for additional information regarding segment information.

Summary of significant accounti

Summary of significant accounting policies	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Summary of significant accounting policies	Summary of significant accounting policies Basis of presentation The accompanying condensed consolidated balance sheet as of September 30, 2021 and the condensed consolidated statements of operations, condensed consolidated statements of comprehensive loss, and condensed consolidated statements of changes in stockholders’ equity for the three and nine months ended September 30, 2021 and 2020 and the condensed consolidated statements of cash flows for the nine months ended September 30, 2021 and 2020 are unaudited. These financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information. Accordingly, they do not include all of the financial information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of the Company’s management, the unaudited condensed consolidated financial statements include all adjustments necessary for the fair presentation of the Company’s balance sheet as of September 30, 2021 and its results of operations, including its comprehensive income, and stockholders’ equity for the three and nine months ended September 30, 2021 and 2020 and cash flows for the nine months ended September 30, 2021 and 2020. All adjustments are of a normal recurring nature. The results for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for any subsequent quarter or for the fiscal year ending December 31, 2021. These unaudited interim consolidated financial statements should be read in conjunction with the annual consolidated financial statements and related notes. Use of estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from the estimates made by management. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to estimates are recognized prospectively. Significant items subject to such estimates and assumptions include, but are not limited to, reserves for incurred but not reported claims, the useful lives of property and equipment, accrued net premiums written from Third-Party Agent (as defined in Item 2) referrals and the valuations of stock-based compensation arrangements and the Sponsor Covered Shares liability (as defined below). Title plants Title plants are carried at cost, with costs incurred to maintain, update and operate title plants expensed as incurred. Because properly maintained title plants have indefinite lives and do not diminish in value with the passage of time, no provision has been made for depreciation or amortization. The Company analyzes the title plants for impairment when events or circumstances indicate that the carrying amount may not be recoverable. This analysis includes, but is not limited to, the effects of obsolescence, duplication, demand and other economic factors. There were no impairments of title plants for the three or nine months ended September 30, 2021 and 2020. In February 2020, we sold a title plant for a total sale price of $3.2 million, including a realized gain of $0.2 million. Reinsurance The Company utilizes excess of loss and quota share reinsurance programs to limit its maximum loss exposure by reinsuring certain risks with other insurers. The Company has two reinsurance treaties: the Excess of Loss Treaty and the Quota Share Treaty. Under the Excess of Loss Treaty, we cede liability over $15.0 million on all files. Excess of loss reinsurance coverage protects the Company from a large loss from a single loss occurrence. The Excess of Loss Treaty provides for ceding liability above the retention of $15.0 million for all policies up to a liability cap of $500.0 million. Under the Quota Share Treaty, during the period from January 1, 2021 to February 23, 2021 the Company ceded 100% of its instant underwriting policies. Effective February 24, 2021, the Company cedes 25% of the written premium on our instantly underwritten policies. During the three and nine months ended September 30, 2020, the Company ceded 100% of its instant underwriting policies. Payments and recoveries on reinsured losses for the Company’s title insurance business were immaterial during the three and nine month periods ended September 30, 2021 and 2020. Income taxes Our effective tax rate for the nine months ended September 30, 2021 and 2020 was (1)% and (2)%, respectively, as a result of our recording a full valuation allowance against the deferred tax assets. In determining the realizability of the net U.S. federal and state deferred tax assets, we consider numerous factors including historical profitability, estimated future taxable income, prudent and feasible tax planning strategies, and the industry in which we operate. As of December 31, 2020, the Company carried a valuation allowance against deferred tax assets as management believes it is more likely than not that the benefit of the net deferred tax assets covered by that valuation allowance will not be realized. A net deferred tax liability has been recorded as of September 30, 2021 and December 31, 2020 o f $1.2 million and $1.0 million, respectively, and is included in accrued expenses and other liabilities within the accompanying condensed consolidated balance sheets. Management reassesses the realization of the deferred tax assets each reporting period. The Company has approximatel y $0.2 million of pre-2018 federal net operating losses subject to expiration beginning in 2036. The remainder of the federal net operating losses have no expiration. The Company’s state net operating losses are subject to various expirations, beginning in 2030. The Company’s 2017 through 2019 tax years remain open to federal and state tax examinations. The Company believes that as of September 30, 2021 it had no material uncertain tax positions. Interest and penalties related to unrecognized tax expenses (benefits) are recognized in income tax expense, when applicable. There were no material liabilities for interest and penalties accrued as of September 30, 2021. Public Warrants and Private Placement Warrants As a result of the Business Combination, the Company assumed the Public Warrants (as defined in Note 3) and the Private Placement Warrants (as defined in Note 3) (collectively, the “Warrants”) as of the Closing Date. The Warrants meet the definition of derivatives as contemplated in Accounting Standards Codification (“ASC”) 815. As such, the Warrants were recorded as liabilities on the balance sheet at fair value upon the consummation of the Business Combination, with subsequent changes in their respective fair values recognized in the condensed consolidated statement of operations at each reporting period. Sponsor Covered Shares and Seller Earnout Shares Immediately after the Closing Date, certain common stock held by the Sponsor (as defined in Note 3) became subject to vesting, contingent upon the price of Doma’s common stock, par value $0.0001 (“Doma common stock”) exceeding certain thresholds (the “Sponsor Covered Shares”). The Sponsor Covered Shares are accounted for as a derivative due to the settlement adjustments upon change in control transactions that are not deemed to be indexed to Doma common stock. As such, the Sponsor Covered Shares were recorded as liabilities on the balance sheet at fair value upon the consummation of the Business Combination, with subsequent changes in their respective fair values recognized in the condensed consolidated statement of operations at each reporting period. Also following the Closing Date, equity holders of Old Doma prior to the Business Combination (the “Sellers”) have the right to receive an additional number of shares contingent on the price of Doma common stock. The Seller Earnout Shares (as defined in Note 3) are treated as an equity classified contract because all settlement scenarios, including those under fundamental change events, are indexed to Doma common stock (see Note 3 for additional information). Share counts of Doma common stock provided in this Quarterly Report exclude both the Sponsor Covered Shares and the Seller Earnout Shares. Concentration of credit risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in financial institutions and our investment portfolio. The Company has not experienced losses on the cash accounts and management believes the Company is not exposed to significant risks on such accounts. Additionally, we manage the exposure to credit risk in our portfolio by investing in high quality securities and diversifying our holdings. Our investment portfolio is comprised of corporate debt, certificates of deposit, mortgages, U.S. government agency obligations and U.S. Treasuries. Coronavirus outbreak The COVID-19 global pandemic has caused national and global economic and financial market disruptions. On the onset of the pandemic, the Company braced and anticipated uncertain disruption to our business. Our results from operations for the three and nine months ended September 30, 2021, show that the Company’s performance from operations was not adversely impacted in a material manner. The Company continues to monitor and react to business disruptions caused by the pandemic but we cannot predict with certainty the duration of the pandemic or its impact on the Company’s financial condition and results of operations, as well as business operations and workforce. Emerging Growth Company and Smaller Reporting Company Subsequent to the Business Combination described in Note 3, the Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s condensed financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Additionally, subsequent to the Business Combination described in Note 3, the Company is a “smaller reporting company” as defined in Item 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements. Recently issued and adopted accounting pronouncements No new accounting policies were recently issued and adopted in the three or nine months ended September 30, 2021. Recently issued but not adopted accounting pronouncements In June 2016, the FASB issued ASU No. 2016-13 Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments (Topic 326). The amendments in this and the related ASUs introduce broad changes to accounting for credit impairment of financial instruments. The primary updates include the introduction of a new current expected credit loss (”CECL”) model that is based on expected rather than incurred losses and amendments to the accounting for impairment of held-to-maturity securities and available-for-sale securities. The amendments in this update are effective for public entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. For all other entities, the amendment is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company currently expects to adopt Topic 326 under the private company transition guidance beginning January 1, 2022. The Company is currently evaluating the impact the adoption of Topic 326 will have on the Company’s financial statements, however management currently believes that the adoption will not have a significant impact on the Company's financial position and results of operations. We have not early adopted this standard. In February 2016, the FASB issued ASU 2016-02, Leases (”ASU 2016-02”), which provides guidance for accounting for leases. ASU 2016-02 requires lessees to classify leases as either finance or operating leases and to record a right-of-use asset and a lease liability for all leases with a term greater than 12 months regardless of the lease classification. The lease classification will determine whether the lease expense is recognized based on an effective interest rate method or on a straight-line basis over the term of the lease. The amendments in this update

Business Combination

Business Combination	9 Months Ended
	Sep. 30, 2021
Reverse Recapitalization [Abstract]
Business Combination	Business Combination As described in Note 1, on March 2, 2021, Old Doma entered into the Agreement with Capitol, a blank check company incorporated in the State of Delaware and formed for the purpose of effecting a merger. Pursuant to the Agreement, a newly formed subsidiary of Capitol was merged with and into Old Doma, and the Business Combination was completed on July 28, 2021. The Business Combination was accounted for as a reverse recapitalization and Capitol was treated as the acquired company for financial statement reporting purposes. Old Doma was deemed the predecessor for financial reporting purposes and Doma was deemed the successor SEC registrant, meaning that Old Doma’s financial statements for periods prior to the consummation of the Business Combination are disclosed in the financial statements included within this Quarterly Report and will be disclosed in Doma’s future periodic reports. No goodwill or other intangible assets were recorded, in accordance with GAAP. At the Closing Date, Doma received gross cash consideration of $345.0 million as a result of the reverse recapitalization from Capitol’s trust account, which was then reduced by the redemption of Class A common stock of $294.9 million. In addition, existing Old Doma stockholders and option holders received cash payments from the settlement of the net proceeds of the Business Combination totaling $20.1 million. In connection with the Business Combination, Capitol entered into subscription agreements with certain investors, whereby Doma issued 30,000,000 shares of common stock at $10.00 per share for an aggregate purchase price of $300.0 million (“PIPE Investment”), which closed simultaneously with the consummation of the Business Combination. Upon the Closing Date, holders of Old Doma common stock, par value $0.0001 per share (“Old Doma Common Stock”) received shares of Doma common stock in an amount determined by the exchange ratio of approximately 5.994933 to 1 (the “Exchange Ratio”), which was based on the implied price per share prior to the Business Combination established within the Agreement. Reported shares and earnings per share available to holders of Old Doma’s Common Stock, prior to the Business Combination, have been retroactively restated as shares reflecting the Exchange Ratio. Applicable share activity within the statement of changes in stockholder’s equity were also retroactively converted to Doma common stock at the Exchange Ratio. Old Doma recorded the net assets acquired from Capitol. The total estimated transaction costs directly attributable to the Business Combination are approximately $67.0 million, of which $63.2 million have been paid, consisting of advisory, legal, share registration and other professional fees. $12.1 million of these fees represent underwriter fees incurred by Capitol prior to the Business Combination related to their initial public offering. Immediately after giving effect to the Business Combination and the PIPE Investment, there were 321,461,822 shares of common stock outstanding, which excludes the 1,325,664 of Sponsor Covered Shares. The Company is authorized to issue 2,000,000,000 shares of common stock having a par value of $0.0001 per share. Additionally, the Company is authorized to issue 100,000,000 shares of preferred stock having a par value of $0.0001 per share. As of September 30, 2021, there were 321,544,052 and 0 shares of common stock and preferred stock issued and outstanding, respectively, which excludes the 1,325,664 of Sponsor Covered Shares. On December 4, 2020, Capitol consummated its initial public offering, which included the issuance of 11,500,000 redeemable warrants (the “Public Warrants”). Simultaneously with the closing of the initial public offering, Capitol completed the private sale of 5,833,333 warrants (the “Private Placement Warrants”). These Warrants remain outstanding following the Business Combination and each whole warrant entitles the holder to purchase one share of Doma common stock at a price of $11.50 (see Note 16 for additional information). Immediately after the Closing Date, 20% of the aggregate of Doma common stock held by certain investors (collectively, the “Sponsor”) became subject to vesting, contingent upon the price of Doma common stock exceeding certain thresholds. The Sponsor Covered Shares will vest in two tranches: (i) one-half of such shares shall vest if the last reported sale price of the common stock equals or exceeds $15.00 for any 20 trading days within any 30-day trading period ending on or before the tenth anniversary of the Closing Date, and (ii) one-half of such shares shall vest if the last reported sale price of the common stock equals or exceeds $17.50 for any 20 trading days within any 30-day trading period ending on or before the tenth anniversary of the Closing Date. The Sponsor is also entitled to the Sponsor Covered Shares if a covered strategic transaction or change in control, as defined by the sponsor support agreement dated as of March 2, 2021 (the “Sponsor Support Agreement”) by and among the sponsors named thereto, Capitol and Old Doma, occurs prior to the ten Also following the Closing Date, the Sellers have the contingent right to receive up to an additional number of shares equal to 5% of the sum of (i) the aggregate number of outstanding shares of Doma common stock (including restricted common stock, but excluding Sponsor Covered Shares), plus (ii) the maximum number of shares underlying Doma options that are vested and the maximum number of shares underlying warrants to purchase shares of Doma common stock issued as replacement warrants for Old Doma warrants, in each case of these clauses (i) and (ii), as of immediately following the Closing Date (“Seller Earnout Shares”). The Seller Earnout Shares are contingently issuable to the Sellers in two tranches: (i) one-half of such shares shall be issued if the last reported sale price of the common stock equals or exceeds $15.00 for any 20 trading days within any 30-day trading period ending on or before the fifth anniversary of the Closing Date, and (ii) one-half of such shares shall be issued if the last reported sale price of the common stock equals or exceeds $17.50 for any 20 trading days within any 30-day trading period ending on or before the fifth anniversary of the Closing Date. Since none of the conditions of the Seller Earnout Shares were met as of September 30, 2021, no related shares are included in the Company’s condensed consolidated statements of changes in stockholders’ equity as of September 30, 2021 or for purposes of calculating earnings per share.

Investments and fair value meas

Investments and fair value measurements	9 Months Ended
	Sep. 30, 2021
Investments, All Other Investments [Abstract]
Investments and fair value measurements	Investments and fair value measurements Held-to-maturity debt securities The cost basis, fair values and gross unrealized gains and losses of our held-to-maturity debt securities are as follows: September 30, 2021 December 31, 2020 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Amortized Cost Unrealized Gains Unrealized Losses Fair Value Corporate debt securities (1) $ 69,670 $ 766 $ (43) $ 70,393 $ 57,651 $ 994 $ (53) $ 58,592 U.S. Treasury securities 4,965 3 (1) 4,967 7,519 54 — 7,573 Certificates of deposit 237 — — 237 236 — — 236 Total $ 74,872 $ 769 $ (44) $ 75,597 $ 65,406 $ 1,048 $ (53) $ 66,401 _______________ (1) Includes both U.S. and foreign corporate debt securities. The cost basis of held-to-maturity debt securities includes an adjustment for the amortization of premium or discount since the date of purchase. Held-to-maturity debt securities valued at approximately $4.6 million and $5.1 million were on deposit with various governmental authorities at September 30, 2021 and December 31, 2020, respectively, as required by law. The change in net unrealized gains and losses on held-to-maturity debt securities for the nine months ended September 30, 2021 and 2020 was $(0.3) million and $0.7 million, respectively. The following table reflects the composition of net realized gains or losses and corresponding proceeds for the sales of the securities for each of the periods shown below: Three months ended September 30, Nine months ended September 30, 2021 2020 2021 2020 Realized gains (losses): Held-to-maturity debt securities: Gains $ — $ — $ 65 $ 15 Losses — — (11) — Net $ — $ — $ 54 $ 15 Proceeds from sales $ — $ — $ 3,048 $ 1,504 Net realized gains on disposition of held-to-maturity debt securities are computed using the specific identification method and are included in the condensed consolidated statements of operations. The following table presents certain information regarding contractual maturities of our held-to-maturity debt securities: Maturity September 30, 2021 Amortized Cost % of Total Fair Value % of Total One year or less $ 24,951 33 % $ 25,103 33 % After one year through five years $ 49,921 67 % $ 50,494 67 % Total $ 74,872 100 % $ 75,597 100 % There were no held-to-maturity debt securities with contractual maturities after five years. Expected maturities may differ from contractual maturities because certain borrowers have the right to call or prepay obligations with or without call or prepayment penalties. Net unrealized losses on held-to-maturity debt securities and the fair value of the related securities, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position are as follows: September 30, 2021 December 31, 2020 Corporate debt securities U.S. Treasury securities Certificate of deposits Total Corporate debt securities U.S. Treasury securities Certificate of deposits Total Less than 12 months Fair value $ 5,934 $ 1,676 $ — $ 7,610 $ 8,464 $ 5,181 $ — $ 13,645 Unrealized losses $ (38) $ (1) $ — $ (39) $ (53) $ — $ — $ (53) Greater than 12 months Fair value $ 151 $ — $ — $ 151 $ — $ — $ — $ — Unrealized losses $ (5) $ — $ — $ (5) $ — $ — $ — $ — Total Fair value $ 6,085 $ 1,676 $ — $ 7,761 $ 8,464 $ 5,181 $ — $ 13,645 Unrealized losses $ (43) $ (1) $ — $ (44) $ (53) $ — $ — $ (53) We believe that any unrealized losses on our held-to-maturity debt securities at September 30, 2021 are temporary based upon our current analysis of the issuers of the securities that we hold and current market conditions. We have no intent to sell, and it is more likely than not that we will not be required to sell, these securities until the fair value recovers to at least equal our cost basis or the securities mature. Available-for-sale debt securities The cost basis, fair values and gross unrealized gains and losses of our available-for-sale debt securities are as follows: December 31, 2020 Cost Basis Unrealized Gains Unrealized Losses Fair Value Corporate debt securities (1) $ 7,139 $ 918 $ — $ 8,057 Total $ 7,139 $ 918 $ — $ 8,057 _________________ (1) Includes both U.S. and foreign corporate debt securities. The cost basis of available-for-sale debt securities includes an adjustment for the amortization of premium or discount since the date of purchase. The change in net unrealized gains on available-for-sale debt securities for the nine months ended September 30, 2021 and 2020 wa s $(0.9) million and $(0.1) million, r espectively. The Company disposed all available-for-sale debt securities in the three months ended March 31, 2021 and therefore had no unrealized gain or loss as of September 30, 2021 and no change in net unrealized gains on available-for-sale debt securities for the three months ended September 30, 2021. The change in net unrealized gains on available-for sale debt securities for the three months ended September 30, 2020 was $0.6 million . Any unrealized holding gains or losses on available-for-sale debt securities as of December 31, 2020 are reported as accumulated other comprehensive gain or loss, which is a separate component of stockholders’ equity, net of tax, until realized. The following table reflects the composition of net realized gains or losses and corresponding proceeds for the sales of the securities: Three months ended September 30, Nine months ended September 30, 2021 2020 2021 2020 Realized gains (losses): Available-for-sale debt securities: Gains $ — $ — $ 768 $ — Losses — — (90) — Net $ — $ — $ 678 $ — Proceeds from sales $ — $ — $ 7,817 $ — Net realized gains on disposition of available-for-sale debt securities are computed using the specific identification method and are included in the condensed consolidated statements of operations. Equity securities The cost and estimated fair value of equity securities are as follows: September 30, 2021 December 31, 2020 Cost Estimated Fair Value Cost Estimated Fair Value Preferred stocks $ — $ — $ 2,000 $ 2,119 Total $ — $ — $ 2,000 $ 2,119 The Company disposed of all equity securities in the three months ended March 31, 2021. Mortgage loans The mortgage loan portfolio as of September 30, 2021 is comprised entirely of residential mortgage loans. During the nine months ended September 30, 2021, the Company did not purchase any new mortgage loans. Mortgage loans, which include original contractual terms to maturity of thirty years, are not categorized by contractual maturity as borrowers may have the right to call or prepay obligations with, or without, call or prepayment penalties. The cost and estimated fair value of mortgage loans are as follows: September 30, 2021 December 31, 2020 Cost Estimated Fair Value Cost Estimated Fair Value Mortgage loans $ 2,920 $ 2,920 $ 2,980 $ 2,980 Total $ 2,920 $ 2,920 $ 2,980 $ 2,980 Investment income Investment income from securities, inclusive of realized gains (losses), consists of the following: Three months ended September 30, Nine months ended September 30, 2021 2020 2021 2020 Available-for-sale debt securities $ — $ 102 $ 773 $ 306 Held-to-maturity debt securities 543 465 1,507 987 Equity investments — 166 (89) 56 Mortgage loans 45 46 136 149 Other — 4 61 157 Total $ 588 $ 783 $ 2,388 $ 1,655 Accrued interest receivable Accrued interest receivable from investments is included in receivables, net on the condensed consolidated balance sheets. The following table reflects the composition of accrued interest receivable for investments: September 30, 2021 December 31, 2020 Corporate debt securities $ 568 $ 641 U.S. Treasury securities 38 45 Accrued interest receivable on investment securities $ 606 $ 686 Mortgage loans 21 43 Accrued interest receivable on investments $ 627 $ 729 Fair value measurement ASC 820, “Fair Value Measurements and Disclosures” (“ASC 820”) establishes a fair value hierarchy that prioritizes and ranks the level of observability of inputs used to measure financial assets or liabilities at fair value. The observability of inputs is impacted by a number of factors, including the type of asset or liability, characteristics specific to the asset or liability, market conditions and other factors. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under ASC 820 are as follows: Level 1 Quoted prices (unadjusted) in active markets for identical asset or liability at the measurement date are used. Level 2 Pricing inputs are other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 pricing inputs include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability, and inputs that are derived principally from or corroborated by observable market data by correlation or other means. Level 3 Pricing inputs are unobservable and include situations where there is little, if any, market activity for the asset or liability. The inputs used in determination of fair value require significant judgment and estimation. When fair value inputs fall within different levels of the fair value hierarchy, the level in the fair value hierarchy within which the asset or liability is categorized in its entirety is determined based on the lowest level input that is significant to the asset or liability. Assessing the significance of a particular input to the valuation of an asset or liability in its entirety requires judgment and considers factors specific to the asset or liability. The categorization of an asset or liability within the hierarchy is based upon the pricing transparency of the asset or liability and does not necessarily correspond to the perceived risk of that asset or liability. The Company’s assets in the following table are presented at amortized cost on the accompanying condensed consolidated balance sheets. The following table summarizes the Company’s assets measured at fair value: Assets Corporate debt securities U.S. Treasury securities Mortgage loans Preferred stocks Certificate of deposits Total September 30, 2021 Level 1 $ — $ 4,967 $ — $ — $ — $ 4,967 Level 2 70,393 — — — 237 70,630 Level 3 — — 2,920 — — 2,920 Total $ 70,393 $ 4,967 $ 2,920 $ — $ 237 $ 78,517 December 31, 2020 Level 1 $ — $ 7,573 $ — $ 2,119 $ — $ 9,692 Level 2 66,649 — — — 236 66,885 Level 3 — — 2,980 — — 2,980 Total $ 66,649 $ 7,573 $ 2,980 $ 2,119 $ 236 $ 79,557 The Company classifies U.S. Treasury bonds and preferred stocks within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. Corporate debt securities and certificates of deposit are classified within Level 2 because they are valued using inputs other than quoted prices that are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security which may not be actively traded. The Company classifies mortgage loans as Level 3 due to the reliance on significant unobservable valuation inputs. The Company’s liabilities in the following table are presented at fair value on the accompanying condensed consolidated balance sheets. The following table summarizes the Company’s liabilities measured at fair value: Liabilities Public Warrants Private Placement Warrants Sponsor Covered Shares Total September 30, 2021 Level 1 $ 16,215 $ — $ — $ 16,215 Level 2 — 8,225 — 8,225 Level 3 — — 8,610 8,610 Total $ 16,215 $ 8,225 $ 8,610 $ 33,050 December 31, 2020 Level 1 $ — $ — $ — $ — Level 2 — — — — Level 3 — — — — Total $ — $ — $ — $ — The Company considers the Public Warrants to be Level 1 liabilities due to the use of an observable market quote in an active market under the ticker DOMA.WS. For the Private Placement Warrants, the Company considers the fair value of each Private Placement Warrant to be equivalent to that of each Public Warrant, with an immaterial adjustment for short-term marketability restrictions. As such, the Private Placement Warrants are classified as Level 2. The fair value of the Sponsor Covered Shares was determined using a Monte Carlo simulation valuation model using a distribution of potential stock price outcomes on a daily basis over the 10-year vesting period. The unobservable significant inputs to the valuation model were as follows: September 30, Current stock price $ 7.40 Expected volatility 55.2 % Risk-free interest rate 1.50 % Expected term 9.83 years Expected dividend yield — % Annual change in control probability 2.0 % The changes for Level 3 items measured at fair value on a recurring basis using significant unobservable inputs are as follows: Sponsor Covered Shares Fair value as of June 30, 2021 $ — Sponsor Covered Shares assumed in Business Combination 9,332 Change in fair value of Sponsor Covered Shares (722) Fair value as of September 30, 2021 $ 8,610 There were no transfers of assets or liabilities between Level 1 and Level 2 during the three or nine months ended September 30, 2021 and the year ended December 31, 2020. There were no transfers involving Level 3 assets or liabilities during the three or nine months ended September 30, 2021 and the year ended December 31, 2020.

Revenue recognition

Revenue recognition	9 Months Ended
	Sep. 30, 2021
Revenue from Contract with Customer [Abstract]
Revenue recognition	Revenue recognition Disaggregation of revenue Our revenue consists of: Three months ended Nine months ended 2021 2020 2021 2020 Revenue Stream Statement of Operations Classification Segment Total Revenue Revenue from insurance contracts: Direct Agents title insurance premiums Net premiums written Underwriting $ 32,944 $ 23,146 $ 88,797 $ 59,399 Direct Agents title insurance premiums Net premiums written Elimination (96) — (976) — Third-Party Agents title insurance premiums Net premiums written Underwriting 108,643 80,441 270,933 187,339 Total revenue from insurance contracts $ 141,491 $ 103,587 $ 358,754 $ 246,738 Revenue from contracts with customers: Escrow fees Escrow, title-related and other fees Distribution $ 16,190 $ 11,456 $ 45,325 $ 29,331 Other title-related fees and income Escrow, title-related and other fees Distribution 31,383 24,638 86,181 63,712 Other title-related fees and income Escrow, title-related and other fees Underwriting 823 490 2,621 1,088 Other title-related fees and income Escrow, title-related and other fees Elimination (1) (27,944) (19,842) (75,035) (50,833) Total revenue from contracts with customers $ 20,452 $ 16,742 $ 59,092 $ 43,298 Other revenue: Interest and investment income (2) Investment, dividend and other income Distribution 68 33 155 304 Interest and investment income (2) Investment, dividend and other income Underwriting 493 659 1,483 1,513 Realized gains and losses, net Investment, dividend and other income Distribution (21) (73) (25) 310 Realized gains and losses, net Investment, dividend and other income Underwriting 99 124 905 141 Total other revenues $ 639 $ 743 $ 2,518 $ 2,268 Total revenues $ 162,582 $ 121,072 $ 420,364 $ 292,304 _________________ (1) Premiums retained by Direct Agents are recognized as income to the Distribution segment, and expense to the Underwriting segment. Upon consolidation, the impact of these internal segment transactions is eliminated. See Note 7. Segment information for additional breakdown. (2) Interest and investment income consists primarily of interest payments received on held-to-maturity debt securities, available-for-sale debt securities and mortgage loans.

Liability for loss and loss adj

Liability for loss and loss adjustment expenses	9 Months Ended
	Sep. 30, 2021
Insurance [Abstract]
Liability for loss and loss adjustment expenses	Liability for loss and loss adjustment expenses A summary of the changes in the liability for loss and loss adjustment expenses for the nine months ending September 30, 2021 and 2020 is as follows: September 30, 2021 2020 Balance at the beginning of the year $ 69,800 $ 62,758 Provision for claims related to: Current year $ 23,567 $ 15,761 Prior years (6,826) (5,696) Total provision for claims $ 16,741 $ 10,065 Paid losses related to: Current year $ (2,832) $ (1,636) Prior years (5,038) (5,055) Total paid losses $ (7,870) $ (6,691) Balance at the end of the period $ 78,671 $ 66,132 Provision for claims as a percentage of net written premiums 4.7 % 4.1 % We continually update our liability for loss and loss adjustment expense estimates as new information becomes known, new loss patterns emerge, or as other contributing factors and judgments are considered and incorporated into the analysis. Estimating future title loss payments is difficult because of the complex nature of title claims, the long periods of time over which claims are paid, significantly varying dollar amounts of individual claims, and other factors. For the nine months ended September 30, 2021, the provision for claims reserve release related to prior years of $6.8 million is due to expected loss emergence being lower than prior expectations. Historically, our favorable loss experience has resulted in a decrease in the projection of ultimate loss for past policy years. Most recently, our favorable loss experience resulted in a decrease in the projection of ultimate loss for policy years 2017-2020. For the nine months ended September 30, 2020, the provision for claims reserve release related to prior years of $5.7 million is due to reported loss emergence which was lower than expected. This resulted in a decrease in the projection of ultimate loss primarily for policy years 2017-2019. The actuarial assumptions underlying the Company’s selected ultimate loss estimates place more consideration on title insurance industry benchmarks for more recent policy years. These title insurance benchmarks are based on industry long-term average loss ratios. As the Company’s claims experience matures, we refine those estimates to put more consideration to the Company’s actual claims experience. For the nine months ended September 30, 2021 and 2020, the Company’s actual claims experience reflects lower loss ratios than industry benchmarks from a current positive underwriting cycle and resulted in the favorable development. Current year incurred and paid losses includes current year reported claims as well as estimated future losses on such claims. The liability for loss and loss adjustment expenses of $78.7 million and $69.8 million, as of September 30, 2021 and December 31, 2020, respectively, includes $0.2 and $0.7 million, respectively, of reserves for the settlement of claims which the Company has deemed to be directly related to its escrow or agent related activities. The reserves for the settlement of claims related to escrow or agent related activities are not actuarially determined.

Segment information

Segment information	9 Months Ended
	Sep. 30, 2021
Segment Reporting [Abstract]
Segment information	Segment information A description of each of our reportable segments is as follows. • Distribution: Our Distribution segment reflects our Direct Agents operations of acquiring customer orders and providing title and escrow services for real estate closing transactions. We acquire customers through our partnerships with realtors, attorneys and non-centralized loan originators via a 94-branch footprint across ten states (“Local”) and our partnerships with national lenders and mortgage originators that maintain centralized lending operations representing our Doma Enterprise accounts (“Doma Enterprise”). • Underwriting: Our Underwriting segment reflects the results of our title insurance underwriting business, including policies referred through our Direct Agents and Third-Party Agents channels. The referring agents typically retain approximately 84% of the policy premiums in exchange for their services. The retention varies by state and agent. We use adjusted gross profit as the primary profitability measure for making decisions regarding ongoing operations. Adjusted gross profit is calculated by subtracting direct costs, such as premiums retained by agents, direct labor, other direct costs, and provision for claims, from total revenue. Our chief operating decision maker evaluates the results of the aforementioned segments on a pre-tax basis. Segment adjusted gross profit excludes certain items which are included in net loss, such as depreciation and amortization, corporate and other expenses, change in the fair value of Warrant and Sponsor Covered Shares liabilities, interest expense, and income tax expense, as these items are not considered by the chief operating decision maker in evaluating the segments’ overall operating performance. Our chief operating decision maker does not review nor consider assets allocated to our segments for the purpose of assessing performance or allocating resources. Accordingly, segments’ assets are not presented. The following table summarizes the operating results of the Company’s reportable segments: Three months ended September 30, 2021 Distribution Underwriting Eliminations Consolidated total Net premiums written $ — $ 141,587 $ (96) $ 141,491 Escrow, other title-related fees and other (1) 47,573 823 (27,944) 20,452 Investment, dividend and other income 47 592 — 639 Total revenue $ 47,620 $ 143,002 $ (28,040) $ 162,582 Premiums retained by agents (2) $ — $ 119,636 $ (28,040) $ 91,596 Direct labor (3) 21,791 2,157 — 23,948 Other direct costs (4) 5,650 4,423 — 10,073 Provision for claims 1,243 5,442 — 6,685 Adjusted gross profit $ 18,936 $ 11,344 $ — $ 30,280 Nine months ended September 30, 2021 Distribution Underwriting Eliminations Consolidated total Net premiums written $ — $ 359,730 $ (976) $ 358,754 Escrow, other title-related fees and other (1) 131,506 2,621 (75,035) 59,092 Investment, dividend and other income 130 2,388 — 2,518 Total revenue $ 131,636 $ 364,739 $ (76,011) $ 420,364 Premiums retained by agents (2) $ — $ 303,126 $ (76,011) $ 227,115 Direct labor (3) 56,884 5,945 — 62,829 Other direct costs (4) 16,846 7,896 — 24,742 Provision for claims 1,777 14,964 — 16,741 Adjusted gross profit $ 56,129 $ 32,808 $ — $ 88,937 Three months ended September 30, 2020 Distribution Underwriting Eliminations Consolidated total Net premiums written $ — $ 103,587 $ — $ 103,587 Escrow, other title-related fees and other (1) 36,094 490 (19,842) 16,742 Investment, dividend and other income (40) 783 — 743 Total revenue $ 36,054 $ 104,860 $ (19,842) $ 121,072 Premiums retained by agents (2) $ — $ 86,866 $ (19,842) $ 67,024 Direct labor (3) 13,185 1,707 — 14,892 Other direct costs (4) 4,711 1,603 — 6,314 Provision for claims 617 4,625 — 5,242 Adjusted gross profit $ 17,541 $ 10,059 $ — $ 27,600 Nine months ended September 30, 2020 Distribution Underwriting Eliminations Consolidated total Net premiums written $ — $ 246,738 $ — $ 246,738 Escrow, other title-related fees and other (1) 93,043 1,088 (50,833) 43,298 Investment, dividend and other income 614 1,654 — 2,268 Total revenue $ 93,657 $ 249,480 $ (50,833) $ 292,304 Premiums retained by agents (2) $ — $ 206,965 $ (50,833) $ 156,132 Direct labor (3) 40,213 4,891 — 45,104 Other direct costs (4) 12,433 3,916 — 16,349 Provision for claims 1,006 9,059 — 10,065 Adjusted gross profit $ 40,005 $ 24,649 $ — $ 64,654 _________________ (1) Includes fee income from closings, escrow, title exams, ceding commission income, as well as premiums retained by Direct Agents. (2) This expense represents a deduction from the net premiums written for the amounts that are retained by Direct Agents and Third-Party Agents as compensation for their efforts to generate premium income for our Underwriting segment. The impact of premiums retained by our Direct Agents and the expense for reinsurance or co-insurance procured on Direct Agents sourced premiums are eliminated in consolidation. (3) Includes all compensation costs, including salaries, bonuses, incentive payments, and benefits, for personnel involved in the direct fulfillment of title and/or escrow services. (4) Includes title examination expense, office supplies, and premium and other taxes. The following table provides a reconciliation of the Company’s total reportable segments’ adjusted gross profit to its total loss before income taxes: Three months ended September 30, Nine months ended September 30, 2021 2020 2021 2020 Adjusted gross profit $ 30,280 $ 27,600 $ 88,937 $ 64,654 Depreciation and amortization 1,978 1,221 7,705 3,236 Corporate and other expenses (1) 53,393 28,604 133,234 82,910 Change in fair value of Warrant and Sponsor Covered Shares liabilities 4,478 — 4,478 — Interest expense 4,531 1,193 12,341 4,428 Loss before income taxes $ (34,100) $ (3,418) $ (68,821) $ (25,920) _________________ (1) Includes corporate and other costs not allocated to segments including corporate support function costs, such as legal, finance, human resources, technology support and certain other indirect operating expenses, such as sales and management payroll, and incentive related expenses.

Debt

Debt	9 Months Ended
	Sep. 30, 2021
Debt Disclosure [Abstract]
Debt	Debt Senior secured credit agreement On December 31, 2020, Old Doma executed a loan and security agreement with Hudson Structured Capital Management Ltd. (“HSCM”), providing for a $150.0 million senior secured term loan (“Senior Debt”). On January 14, 2021 Old Doma executed a notice of borrowing, committing Old Doma to borrow $150.0 million under the terms and conditions of the Senior Debt. The Senior Debt was funded, by the lenders, which are affiliates of HSCM on January 29, 2021 (“Funding Date”). The Senior Debt matures five years from the Funding Date. Under the agreement, the Senior Debt will bear interest of 11.25% per annum, 5.0% of which will be paid on a current cash basis and the remainder to accrue and be added to the outstanding principal balance. Interest shall be compounded quarterly. If at any time Old Doma (now known as States Title) is in an event of default under the Senior Debt, outstanding amounts shall bear interest at the default interest rate of 15.00%. Upon funding, Old Doma issued penny warrants to affiliates of HSCM equal to 1.35% of Old Doma’s fully diluted shares. The warrants were net exercised on the Closing Date and such affiliates of HSCM received the right to receive approximately 4.2 million shares of Doma common stock. The Senior Debt is secured by a first-priority pledge and security interest in substantially all of the assets (tangible and intangible) of the Company and any of its existing and future domestic subsidiaries (in each case, subject to customary exclusions, including the exclusion of regulated insurance company subsidiaries). The Company is subject to customary affirmative, negative and financial covenants, including, among other things, minimum liquidity of $20.0 million (as of the last day of any month), minimum consolidated annual revenue of $130.0 million, limits on the incurrence of indebtedness, restrictions on asset sales outside the ordinary course of business and material acquisitions, limitations on dividends and other restricted payments. The Company was in compliance with the Senior Debt covenants as of September 30, 2021. The Senior Debt also includes customary events of default for facilities of this type and provides that, if an event of default occurs and is continuing, the Senior Debt will amortize requiring regular payments on a straight-line basis over the subsequent 24-month calendar period, but not to extend beyond the maturity date. Loan from a related party As part of the North American Title Acquisition, Lennar issued Old Doma a note for $87.0 million at January 7, 2019 (the “Loan”). As of December 31, 2020, the Loan had an outstanding balance of $65.5 million. The Loan was

Stock compensation expense

Stock compensation expense	9 Months Ended
	Sep. 30, 2021
Share-based Payment Arrangement [Abstract]
Stock compensation expense	Stock compensation expense The Company issues stock options (incentive stock options (“ISOs”) and non-statutory stock options (“NSOs”) and restricted stock awards (“RSAs”) to employees and key advisors under the Company’s 2019 Equity Incentive Plan, which was approved by the board of directors. Granted stock options do not expire for 10 years and have vesting periods ranging from 7 to 60 months. The holder of one stock option may purchase one share of common stock at the underlying strike price. Stock-based compensation expense for the three months ended September 30, 2021 and 2020 was $3.0 million and $0.4 million, respectively. Stock-based compensation expense for the nine months ended September 30, 2021 and 2020 was $9.0 million and $0.9 million, respectively. Stock options (ISO and NSO) During the nine months ended September 30, 2021, the Company had the following stock option activity (option amounts have been retroactively restated as shares reflecting the Exchange Ratio): Number of Stock Options Weighted Average Exercise Price ($) Weighted Average Remaining Contractual Life (In years) Aggregate Intrinsic Value ($) Outstanding as of December 31, 2020 26,492,158 $ 0.53 8.5 $ 374,808 Granted 4,583,033 0.71 9.25 Exercised (4,004,764) 0.43 7.2 Cancelled or forfeited (786,607) 0.66 8.41 Outstanding as of September 30, 2021 26,283,820 $ 0.58 8.03 $ 179,382 Options exercisable as of September 30, 2021 10,412,664 $ 0.49 7.48 $ 71,902 Restricted stock awards (RSAs) During the nine months ended September 30, 2021, the Company had the following non-vested RSA activity (share amounts have been retroactively restated as shares reflecting the Exchange Ratio): Number of RSAs Average Grant Date Fair Value ($) Non-vested at December 31, 2020 1,551,867 $ 0.52 Granted — — Exercised (613,563) 0.38 Cancelled or Forfeited — — Non-vested at September 30, 2021 938,304 $ 0.61

Earnings per share

Earnings per share	9 Months Ended
	Sep. 30, 2021
Earnings Per Share [Abstract]
Earnings per share	Earnings per share The calculation of the basic and diluted EPS is as follows: Three months ended September 30, Nine months ended September 30, 2021 2020 2021 2020 Numerator Net loss attributable to Doma Holdings, Inc. $ (34,270) $ (3,622) $ (69,327) $ (26,540) Denominator Weighted-average common shares – basic and diluted 245,003,754 64,060,987 128,105,954 62,255,035 Net loss per share attributable to Doma Holdings, Inc. shareholders Basic and diluted $ (0.14) $ (0.06) $ (0.54) $ (0.43) As we have reported net loss for each of the periods presented, all potentially dilutive securities are antidilutive. The following potential outstanding shares of common stock w ere excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been antidilutive: As of September 30, 2021 2020 Convertible preferred stock — 183,159,138 Outstanding stock options 26,283,820 27,621,396 Warrants for common stock 18,022,750 28,870,386 Restricted stock units 938,304 2,083,281 Total antidilutive securities 45,244,874 241,734,201

Related party transactions

Related party transactions	9 Months Ended
	Sep. 30, 2021
Related Party Transactions [Abstract]
Related party transactions	Related party transactions Equity held by Lennar In connection with the North American Title Acquisition, subsidiaries of Lennar were granted equity in the Company. As of September 30, 2021, Lennar, through its subsidiaries, held 25.6% of the Company’s outstanding common stock. Loan from Lennar In connection with the North American Title Acquisition, the Company received a loan from Lennar, which was repaid in full in January 2021 (see Note 8 for additional information). Shared services agreements between the Company and Lennar In connection with the North American Title Acquisition, the Company and Lennar entered into a transition services agreement (“TSA”) that provided for certain shared services provided by Lennar to the Company as it incorporated the Acquired Business into its operations, and also for the sharing of expenses in office locations that would contain both Company and Lennar personnel until such time one entity or the other, depending on the location, established separate office space for its personnel and operations. During the three and nine months ended September 30, 2020, the Company paid Lennar $0.0 and $0.3 million, respectively, in settlement of the TSA services arrangement. Additionally, during the nine months ended September 30, 2021 and 2020, the Company paid Lennar approximately $0.1 million and $0.2 million, respectively, for rent associated with shared spaces. Transactions with Lennar In the routine course of its business, North American Title Insurance Company ("NATIC") underwrites title insurance policies for a subsidiary of Lennar. During the three months ended September 30, 2021 and 2020, the Company recorded revenues of $30.3 million and $22.9 million, respectively, from these transactions, which are included within our Underwriting segment. During the three months ended September 30, 2021 and 2020, the Company recorded premiums retained by Third-Party Agents of $24.8 million and $18.4 million, respectively from these transactions. During the nine months ended September 30, 2021 and 2020, the Company recorded revenues of $81.9 million and $64.2 million, respectively, from these transactions. During the nine months ended September 30, 2021 and 2020, the Company recorded premiums retained by Third-Party Agents of $66.6 million and $51.9 million, respectively from these transactions. As of September 30, 2021 and December 31, 2020, the Company had net receivables related to these transactions of $3.4 million and $4.4 million, respectively. These amounts are included in receivables, net on the Company’s condensed consolidated balance sheets. Consulting agreement

Commitment and contingencies

Commitment and contingencies	9 Months Ended
	Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and contingencies	Commitments and contingencies Legal matters The Company is subject to claims and litigation matters in the ordinary course of business. Management does not believe the resolution of any such matters will have a materially adverse effect on the Company’s financial position or results of operations. Commitments and other contingencies The Company leases office space and equipment under non-cancellable lease agreements that expire at various points through 2028. For the three months ended September 30, 2021 and 2020, rental expense under these leases was $2.4 million and $2.4 million, respectively. For the nine months ended September 30, 2021 and 2020, rental expense under these leases was $7.0 million and $7.5 million, respectively. As of September 30, 2021, total future commitments on non-cancelable operating leases with a minimum remaining term in excess of one year are as follows: 2021 $ 2,311 2022 9,059 2023 8,037 2024 6,417 2025 4,724 Thereafter 7,032 Total $ 37,580 The Company also administers escrow deposits as a service to customers, a substantial portion of which are held at third-party financial institutions. Thes e escrow deposits amounted to $511.1 million and $290.9 million a t September 30, 2021 and December 31, 2020, respectively. Such deposits are not reflected on the condensed consolidated balance sheets, but the Company could be contingently liable for them under certain circumstances (for

Accrued expenses and other liab

Accrued expenses and other liabilities	9 Months Ended
	Sep. 30, 2021
Payables and Accruals [Abstract]
Accrued expenses and other liabilities	Accrued expenses and other liabilities Accrued expenses and other liabilities include the following: September 30, December 31, Employee compensation and benefits $ 32,746 $ 23,899 Other 17,441 9,145 Total accrued expenses and other liabilities $ 50,187 $ 33,044

Employee benefit plan

Employee benefit plan	9 Months Ended
	Sep. 30, 2021
Retirement Benefits [Abstract]
Employee benefit plan	Employee benefit plan The Company sponsors a defined contribution 401(k) plan for its employees (the “Retirement Savings Plan”). The Retirement Savings Plan is a voluntary contributory plan under which employees may elect to defer compensation for federal income tax purposes. All full-time employees age 18+ are eligible to enroll in the plan on their first day of employment. The Co mpany provides an employer match up to 50% of the first 6% of elective contributions. There are no matching contributions in excess of 3% of compensation. Company matching contributions begin upon employee enrollment in the Retirement Savings Plan. For the year ended December 31, 2020, the Company made contributions for the benefit of employees of $0.9 million from January 1, 2020 through May 15, 2020. The Company suspended the employer match effective May 16, 2020 and made no contributions for the benefit of employees to the Retirement Savings Plan for the rest of the year through December 31, 2020. The temporary suspension was due to the COVID-19 pandemic and its potential impact on the business, which was not estimable at the time. On January 1, 2021, the Company reinstated matching contributions to the Retirement Savings Plan, according to the aforementioned terms, rates, and limitations. For the three months ended September 30, 2021, the Company made contributions for the benefit of employees of $0.7 million to the Retirement Savings Plan. For the nine months ended September 30, 2021 and 2020, the Company made contributions for the benefit of employees of $2.0 million and $0.9 million to the Retirement Savings Plan.

Research and development

Research and development	9 Months Ended
	Sep. 30, 2021
Research and Development [Abstract]
Research and development	Research and developmentFor the three months ended September 30, 2021 and 2020, research and development expenses were $5.4 million and $1.7 million, respectively. The Company also had capitalized internally developed software costs of $5.3 million and $3.1 million in the three months ended September 30, 2021 and 2020, respectively. Inclusive of capitalized internally developed software costs, our research and development spend was $10.7 million and $4.8 million for the three months ended September 30, 2021 and 2020, respectively. For the nine months ended September 30, 2021 and 2020, research and development expenses were $10.8 million and $4.5 million, respectively. The Company also had capitalized internally developed software costs of $14.2 million and $8.3 million in the nine months ended September 30, 2021 and 2020, respectively. Inclusive of capitalized internally developed software costs, our research and development spend was $25.0 million and $12.8 million for the nine months ended September 30, 2021 and 2020, respectively. Our research and development costs reflect certain payroll-related costs of employees directly associated with such activities, which are included in personnel costs on the condensed consolidated statements of operations. Capitalized internally developed software and acquired software costs are included in fixed assets, net on the condensed consolidated balance sheets.

Warrant liabilities

Warrant liabilities	9 Months Ended
	Sep. 30, 2021
Other Liabilities Disclosure [Abstract]
Warrant liabilities	Warrant liabilitiesAs a result of the Business Combination, the Company assumed, as of the Closing Date, Public Warrants to purchase an aggregate of 11,500,000 shares of Doma common stock and Private Placement Warrants to purchase an aggregate of 5,833,333 shares of Doma common stock. Each whole Warrant entitles the holder to purchase one share of common stock at a price of $11.50. The Warrants are exercisable commencing on December 4, 2021, which is one year from the closing of the initial public offering of Capitol; provided, that we have an effective registration statement under the Securities Act covering Doma common stock. Redemption of Public Warrants when the price per share of Doma common stock equals or exceeds $18.00 Once the Public Warrants become exercisable, the Company may call the Public Warrants for redemption: • in whole and not in part; • at a price of $0.01 per Public Warrant; • upon not less than 30 days’ prior written notice of redemption to each Public Warrant holder; and • if, and only if, the last reported sale price of Doma’s common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and for certain issuances of common stock and equity-linked securities as described above) for any 20 trading days within a 30-trading day period ending three business days before the Company sends to the notice of redemption to the Public Warrant holders. The Company will not redeem the Public Warrants as described above unless a registration statement under the Securities Act covering the issuance of the shares of common stock issuable upon a cashless exercise of the Public Warrants is then effective and a current prospectus relating to those shares of common stock is available throughout the 30-day redemption period, except if the Public Warrants may be exercised on a cashless basis and such cashless exercise is exempt from registration under the Securities Act. Redemption of Public Warrants when the price per share of Doma common stock equals or exceeds $10.00 Once the Public Warrants become exercisable, the Company may redeem the outstanding Public Warrants: • in whole and not in part; • at $0.10 per Public Warrant upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their Public Warrants prior to redemption and receive a number of shares based on the redemption date and the “fair market value” of common stock except as otherwise described below; • if, and only if, the last reported sale price of common stock equals or exceeds $10.00 per share (as adjusted per stock splits, stock dividends, reorganizations, reclassifications, recapitalizations and the like and for certain issuances of common stock and equity-linked securities as described above) on the trading day prior to the date on which the Company sends the notice of redemption to the Public Warrant holders; and • if, and only if, the last reported sale price of common stock is less than $18.00 per share (as adjusted for stock for stock splits, stock dividends, reorganizations, recapitalizations and the like and for certain issuances of common stock and equity-linked securities), the Private Placement Warrants are also concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above. Beginning on the date the notice of redemption is given until the Public Warrants are redeemed or exercised, holders may elect to exercise their Public Warrants on a cashless basis. The “fair market value” of Doma common stock will mean the volume-weighted average price of Doma common stock for the ten The Private Placement Warrants are identical to the Public Warrants except that the Private Placement Warrants, (i) subject to limited exceptions, are not redeemable by us, (ii) may be exercised for cash or on a cashless basis and (iii) are entitled to registration rights (including the shares of Doma common stock issuable upon exercise of the Private Placement Warrants), in each case, so long as they are held by the initial purchasers or any of their permitted transferees (as further described in the warrant agreement, dated as of December 1, 2020, between the On September 3, 2021, the Company filed a Registration Statement on Form S-1 (No. 333-258942), as amended, with the SEC (which was declared effective on September 8, 2021), which related to the issuance of an aggregate of up to 17,333,333 shares of common stock issuable upon the exercise of the Warrants. As of September 30, 2021, the aggregate values of the Public and Private Warrants were $16.2 million and $8.2 million, respectively, representing Warrants outstanding to purchase 11,500,000 shares and 5,833,333 shares , respectively, of Doma's common stock. The Warrants are accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the condensed consolidated balance sheet. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of Warrants and Sponsor Covered Shares liabilities

Subsequent events

Subsequent events	9 Months Ended
	Sep. 30, 2021
Subsequent Events [Abstract]
Subsequent events	Subsequent events The Company filed a Form S-8 registration statement on October 4, 2021. Effective October 5, 2021 the Company’s Board of Directors granted RSAs and performance stock awards (“PSAs”) totaling 10.1 million shares and 3.6 million shares, respectively. The RSAs are subject to time-based vesting, with a majority of the RSAs vesting 25% on the first anniversary of the award date and ratably thereafter for twelve quarters, such that the RSAs will be fully vested on the fourth anniversary of their award date. The PSAs vest on the achievement of certain performance conditions, as established by the Company’s Board of Directors, and are subject to time-based vesting after the performance period. The RSAs and PSAs are measured at fair market value on the date of the grant and stock-based compensation expense is recognized as the shares vest with a corresponding offset credited to additional paid-in-capital. In the preparation of the accompanying condensed consolidated financial statements, the Company has evaluated all material subsequent events or transactions that occurred after the balance sheet date through the date on which the financial statements were issued for potential recognition or disclosure in the Company's financial statements, noting no subsequent events or transactions that require disclosure, aside from those previously discussed.

Summary of significant accoun_2

Summary of significant accounting policies (Policies)	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Basis of presentation	Basis of presentation The accompanying condensed consolidated balance sheet as of September 30, 2021 and the condensed consolidated statements of operations, condensed consolidated statements of comprehensive loss, and condensed consolidated statements of changes in stockholders’ equity for the three and nine months ended September 30, 2021 and 2020 and the condensed consolidated statements of cash flows for the nine months ended September 30, 2021 and 2020 are unaudited. These financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information. Accordingly, they do not include all of the financial information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of the Company’s management, the unaudited condensed consolidated financial statements include all adjustments necessary for the fair presentation of the Company’s balance sheet as of September 30, 2021 and its results of operations, including its comprehensive income, and stockholders’ equity for the three and nine months ended September 30, 2021 and 2020 and cash flows for the nine months ended September 30, 2021 and 2020. All adjustments are of a normal recurring nature. The results for the three and nine months ended September 30, 2021
Use of estimates	Use of estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from the estimates made by management. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to estimates are recognized prospectively. Significant items subject to such estimates and assumptions include, but are not limited to, reserves for incurred but not reported claims, the useful lives of property and equipment, accrued net premiums written from Third-Party Agent (as defined in Item 2) referrals and the valuations of stock-based compensation arrangements and the Sponsor Covered Shares liability (as defined below).
Title plants	Title plants Title plants are carried at cost, with costs incurred to maintain, update and operate title plants expensed as incurred. Because properly maintained title plants have indefinite lives and do not diminish in value with the passage of time, no provision has been made for depreciation or amortization. The Company analyzes the title plants for impairment when events or circumstances indicate that the carrying amount may not be recoverable. This analysis includes, but is not limited to, the effects of obsolescence, duplication, demand and other economic factors.
Reinsurance	Reinsurance The Company utilizes excess of loss and quota share reinsurance programs to limit its maximum loss exposure by reinsuring certain risks with other insurers. The Company has two reinsurance treaties: the Excess of Loss Treaty and the Quota Share Treaty. Under the Excess of Loss Treaty, we cede liability over $15.0 million on all files. Excess of loss reinsurance coverage protects the Company from a large loss from a single loss occurrence. The Excess of Loss Treaty provides for ceding liability above the retention of $15.0 million for all policies up to a liability cap of $500.0 million. Under the Quota Share Treaty, during the period from January 1, 2021 to February 23, 2021 the Company ceded 100% of its instant underwriting policies. Effective February 24, 2021, the Company cedes 25% of the written premium on our instantly underwritten policies. During the three and nine months ended September 30, 2020, the Company ceded 100% of its instant underwriting policies. Payments and recoveries on reinsured losses for the Company’s title insurance business were immaterial during the three and nine month periods ended September 30, 2021 and 2020.
Income taxes	Income taxes Our effective tax rate for the nine months ended September 30, 2021 and 2020 was (1)% and (2)%, respectively, as a result of our recording a full valuation allowance against the deferred tax assets. In determining the realizability of the net U.S. federal and state deferred tax assets, we consider numerous factors including historical profitability, estimated future taxable income, prudent and feasible tax planning strategies, and the industry in which we operate. As of December 31, 2020, the Company carried a valuation allowance against deferred tax assets as management believes it is more likely than not that the benefit of the net deferred tax assets covered by that valuation allowance will not be realized. A net deferred tax liability has been recorded as of September 30, 2021 and December 31, 2020 o f $1.2 million and $1.0 million, respectively, and is included in accrued expenses and other liabilities within the accompanying condensed consolidated balance sheets. Management reassesses the realization of the deferred tax assets each reporting period. The Company has approximatel y $0.2 million of pre-2018 federal net operating losses
Public Warrants and Private Placement Warrants and Sponsored Covered Shares and Seller Earnout Shares	Public Warrants and Private Placement Warrants As a result of the Business Combination, the Company assumed the Public Warrants (as defined in Note 3) and the Private Placement Warrants (as defined in Note 3) (collectively, the “Warrants”) as of the Closing Date. The Warrants meet the definition of derivatives as contemplated in Accounting Standards Codification (“ASC”) 815. As such, the Warrants were recorded as liabilities on the balance sheet at fair value upon the consummation of the Business Combination, with subsequent changes in their respective fair values recognized in the condensed consolidated statement of operations at each reporting period. Sponsor Covered Shares and Seller Earnout Shares Immediately after the Closing Date, certain common stock held by the Sponsor (as defined in Note 3) became subject to vesting, contingent upon the price of Doma’s common stock, par value $0.0001 (“Doma common stock”) exceeding certain thresholds (the “Sponsor Covered Shares”). The Sponsor Covered Shares are accounted for as a derivative due to the settlement adjustments upon change in control transactions that are not deemed to be indexed to Doma common stock. As such, the Sponsor Covered Shares were recorded as liabilities on the balance sheet at fair value upon the consummation of the Business Combination, with subsequent changes in their respective fair values recognized in the condensed consolidated statement of operations at each reporting period. Also following the Closing Date, equity holders of Old Doma prior to the Business Combination (the “Sellers”) have the right to receive an additional number of shares contingent on the price of Doma common stock. The Seller Earnout Shares (as defined in Note 3) are treated as an equity classified contract because all settlement scenarios, including those under fundamental change events, are indexed to Doma common stock (see Note 3 for additional information).
Concentration of credit risk	Concentration of credit risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in financial institutions and our investment portfolio. The Company has not experienced losses on the cash accounts and management believes the Company is not exposed to significant risks on such accounts. Additionally, we manage the exposure to credit risk in our portfolio by investing in high quality securities and diversifying our holdings. Our investment portfolio is comprised of corporate debt, certificates of deposit, mortgages, U.S. government agency obligations and U.S. Treasuries.
Recently issued and adopted accounting pronouncements and recently issued but not adopted accounting pronouncements	Recently issued and adopted accounting pronouncements No new accounting policies were recently issued and adopted in the three or nine months ended September 30, 2021. Recently issued but not adopted accounting pronouncements In June 2016, the FASB issued ASU No. 2016-13 Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments (Topic 326). The amendments in this and the related ASUs introduce broad changes to accounting for credit impairment of financial instruments. The primary updates include the introduction of a new current expected credit loss (”CECL”) model that is based on expected rather than incurred losses and amendments to the accounting for impairment of held-to-maturity securities and available-for-sale securities. The amendments in this update are effective for public entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. For all other entities, the amendment is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company currently expects to adopt Topic 326 under the private company transition guidance beginning January 1, 2022. The Company is currently evaluating the impact the adoption of Topic 326 will have on the Company’s financial statements, however management currently believes that the adoption will not have a significant impact on the Company's financial position and results of operations. We have not early adopted this standard. In February 2016, the FASB issued ASU 2016-02, Leases (”ASU 2016-02”), which provides guidance for accounting for leases. ASU 2016-02 requires lessees to classify leases as either finance or operating leases and to record a right-of-use asset and a lease liability for all leases with a term greater than 12 months regardless of the lease classification. The lease classification will determine whether the lease expense is recognized based on an effective interest rate method or on a straight-line basis over the term of the lease. The amendments in this update
Fair value measurement	Fair value measurement ASC 820, “Fair Value Measurements and Disclosures” (“ASC 820”) establishes a fair value hierarchy that prioritizes and ranks the level of observability of inputs used to measure financial assets or liabilities at fair value. The observability of inputs is impacted by a number of factors, including the type of asset or liability, characteristics specific to the asset or liability, market conditions and other factors. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under ASC 820 are as follows: Level 1 Quoted prices (unadjusted) in active markets for identical asset or liability at the measurement date are used. Level 2 Pricing inputs are other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 pricing inputs include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability, and inputs that are derived principally from or corroborated by observable market data by correlation or other means. Level 3 Pricing inputs are unobservable and include situations where there is little, if any, market activity for the asset or liability. The inputs used in determination of fair value require significant judgment and estimation. When fair value inputs fall within different levels of the fair value hierarchy, the level in the fair value hierarchy within which the asset or liability is categorized in its entirety is determined based on the lowest level input that is significant to the asset or liability. Assessing the significance of a particular input to the valuation of an asset or liability in its entirety requires judgment and considers factors specific to the asset or liability. The categorization of an asset or liability within the hierarchy is based upon the pricing transparency of the asset or liability and does not necessarily correspond to the perceived risk of that asset or liability.

Investments and fair value me_2

Investments and fair value measurements (Tables)	9 Months Ended
	Sep. 30, 2021
Investments, All Other Investments [Abstract]
Summary of Held-to-Maturity Debt Securities	The cost basis, fair values and gross unrealized gains and losses of our held-to-maturity debt securities are as follows: September 30, 2021 December 31, 2020 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Amortized Cost Unrealized Gains Unrealized Losses Fair Value Corporate debt securities (1) $ 69,670 $ 766 $ (43) $ 70,393 $ 57,651 $ 994 $ (53) $ 58,592 U.S. Treasury securities 4,965 3 (1) 4,967 7,519 54 — 7,573 Certificates of deposit 237 — — 237 236 — — 236 Total $ 74,872 $ 769 $ (44) $ 75,597 $ 65,406 $ 1,048 $ (53) $ 66,401 _______________ (1) Includes both U.S. and foreign corporate debt securities.
Schedule of Realized Gain (Loss) on Held-to-Maturity Debt Securities	The following table reflects the composition of net realized gains or losses and corresponding proceeds for the sales of the securities for each of the periods shown below: Three months ended September 30, Nine months ended September 30, 2021 2020 2021 2020 Realized gains (losses): Held-to-maturity debt securities: Gains $ — $ — $ 65 $ 15 Losses — — (11) — Net $ — $ — $ 54 $ 15 Proceeds from sales $ — $ — $ 3,048 $ 1,504
Summary of Investments by Maturity Date	The following table presents certain information regarding contractual maturities of our held-to-maturity debt securities: Maturity September 30, 2021 Amortized Cost % of Total Fair Value % of Total One year or less $ 24,951 33 % $ 25,103 33 % After one year through five years $ 49,921 67 % $ 50,494 67 % Total $ 74,872 100 % $ 75,597 100 %
Schedule of Unrealized Loss on Held-to-Maturity Debt Securities	Net unrealized losses on held-to-maturity debt securities and the fair value of the related securities, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position are as follows: September 30, 2021 December 31, 2020 Corporate debt securities U.S. Treasury securities Certificate of deposits Total Corporate debt securities U.S. Treasury securities Certificate of deposits Total Less than 12 months Fair value $ 5,934 $ 1,676 $ — $ 7,610 $ 8,464 $ 5,181 $ — $ 13,645 Unrealized losses $ (38) $ (1) $ — $ (39) $ (53) $ — $ — $ (53) Greater than 12 months Fair value $ 151 $ — $ — $ 151 $ — $ — $ — $ — Unrealized losses $ (5) $ — $ — $ (5) $ — $ — $ — $ — Total Fair value $ 6,085 $ 1,676 $ — $ 7,761 $ 8,464 $ 5,181 $ — $ 13,645 Unrealized losses $ (43) $ (1) $ — $ (44) $ (53) $ — $ — $ (53)
Summary of Available-for-Sale Debt Securities	The cost basis, fair values and gross unrealized gains and losses of our available-for-sale debt securities are as follows: December 31, 2020 Cost Basis Unrealized Gains Unrealized Losses Fair Value Corporate debt securities (1) $ 7,139 $ 918 $ — $ 8,057 Total $ 7,139 $ 918 $ — $ 8,057 _________________ (1) Includes both U.S. and foreign corporate debt securities.
Schedule of Realized Gain (Loss) on Available-for-Sale Debt Securities	The following table reflects the composition of net realized gains or losses and corresponding proceeds for the sales of the securities: Three months ended September 30, Nine months ended September 30, 2021 2020 2021 2020 Realized gains (losses): Available-for-sale debt securities: Gains $ — $ — $ 768 $ — Losses — — (90) — Net $ — $ — $ 678 $ — Proceeds from sales $ — $ — $ 7,817 $ —
Summary of Cost and Estimated Fair Value of Equity Securities	The cost and estimated fair value of equity securities are as follows: September 30, 2021 December 31, 2020 Cost Estimated Fair Value Cost Estimated Fair Value Preferred stocks $ — $ — $ 2,000 $ 2,119 Total $ — $ — $ 2,000 $ 2,119
Schedule of Cost and Estimated Fair Value of Mortgage Loans and Accrued Interest Receivable	The cost and estimated fair value of mortgage loans are as follows: September 30, 2021 December 31, 2020 Cost Estimated Fair Value Cost Estimated Fair Value Mortgage loans $ 2,920 $ 2,920 $ 2,980 $ 2,980 Total $ 2,920 $ 2,920 $ 2,980 $ 2,980 Accrued interest receivable from investments is included in receivables, net on the condensed consolidated balance sheets. The following table reflects the composition of accrued interest receivable for investments: September 30, 2021 December 31, 2020 Corporate debt securities $ 568 $ 641 U.S. Treasury securities 38 45 Accrued interest receivable on investment securities $ 606 $ 686 Mortgage loans 21 43 Accrued interest receivable on investments $ 627 $ 729
Schedule of Investment Income	Investment income from securities, inclusive of realized gains (losses), consists of the following: Three months ended September 30, Nine months ended September 30, 2021 2020 2021 2020 Available-for-sale debt securities $ — $ 102 $ 773 $ 306 Held-to-maturity debt securities 543 465 1,507 987 Equity investments — 166 (89) 56 Mortgage loans 45 46 136 149 Other — 4 61 157 Total $ 588 $ 783 $ 2,388 $ 1,655
Summary of Company's Assets Measured at Fair Value	The following table summarizes the Company’s assets measured at fair value: Assets Corporate debt securities U.S. Treasury securities Mortgage loans Preferred stocks Certificate of deposits Total September 30, 2021 Level 1 $ — $ 4,967 $ — $ — $ — $ 4,967 Level 2 70,393 — — — 237 70,630 Level 3 — — 2,920 — — 2,920 Total $ 70,393 $ 4,967 $ 2,920 $ — $ 237 $ 78,517 December 31, 2020 Level 1 $ — $ 7,573 $ — $ 2,119 $ — $ 9,692 Level 2 66,649 — — — 236 66,885 Level 3 — — 2,980 — — 2,980 Total $ 66,649 $ 7,573 $ 2,980 $ 2,119 $ 236 $ 79,557
Summary of Company's Liabilities Measured at Fair Value	The Company’s liabilities in the following table are presented at fair value on the accompanying condensed consolidated balance sheets. The following table summarizes the Company’s liabilities measured at fair value: Liabilities Public Warrants Private Placement Warrants Sponsor Covered Shares Total September 30, 2021 Level 1 $ 16,215 $ — $ — $ 16,215 Level 2 — 8,225 — 8,225 Level 3 — — 8,610 8,610 Total $ 16,215 $ 8,225 $ 8,610 $ 33,050 December 31, 2020 Level 1 $ — $ — $ — $ — Level 2 — — — — Level 3 — — — — Total $ — $ — $ — $ —
Summary of the Fair Values of the Sponsor Earnout Shares Using a Monte Carlo Simulation Valuation Model	The fair value of the Sponsor Covered Shares was determined using a Monte Carlo simulation valuation model using a distribution of potential stock price outcomes on a daily basis over the 10-year vesting period. The unobservable significant inputs to the valuation model were as follows: September 30, Current stock price $ 7.40 Expected volatility 55.2 % Risk-free interest rate 1.50 % Expected term 9.83 years Expected dividend yield — % Annual change in control probability 2.0 %
Summary of Changes for Level 3 Items Measured at Fair Value	The changes for Level 3 items measured at fair value on a recurring basis using significant unobservable inputs are as follows: Sponsor Covered Shares Fair value as of June 30, 2021 $ — Sponsor Covered Shares assumed in Business Combination 9,332 Change in fair value of Sponsor Covered Shares (722) Fair value as of September 30, 2021 $ 8,610

Revenue recognition (Tables)

Revenue recognition (Tables)	9 Months Ended
	Sep. 30, 2021
Revenue from Contract with Customer [Abstract]
Summary of Revenue	Our revenue consists of: Three months ended Nine months ended 2021 2020 2021 2020 Revenue Stream Statement of Operations Classification Segment Total Revenue Revenue from insurance contracts: Direct Agents title insurance premiums Net premiums written Underwriting $ 32,944 $ 23,146 $ 88,797 $ 59,399 Direct Agents title insurance premiums Net premiums written Elimination (96) — (976) — Third-Party Agents title insurance premiums Net premiums written Underwriting 108,643 80,441 270,933 187,339 Total revenue from insurance contracts $ 141,491 $ 103,587 $ 358,754 $ 246,738 Revenue from contracts with customers: Escrow fees Escrow, title-related and other fees Distribution $ 16,190 $ 11,456 $ 45,325 $ 29,331 Other title-related fees and income Escrow, title-related and other fees Distribution 31,383 24,638 86,181 63,712 Other title-related fees and income Escrow, title-related and other fees Underwriting 823 490 2,621 1,088 Other title-related fees and income Escrow, title-related and other fees Elimination (1) (27,944) (19,842) (75,035) (50,833) Total revenue from contracts with customers $ 20,452 $ 16,742 $ 59,092 $ 43,298 Other revenue: Interest and investment income (2) Investment, dividend and other income Distribution 68 33 155 304 Interest and investment income (2) Investment, dividend and other income Underwriting 493 659 1,483 1,513 Realized gains and losses, net Investment, dividend and other income Distribution (21) (73) (25) 310 Realized gains and losses, net Investment, dividend and other income Underwriting 99 124 905 141 Total other revenues $ 639 $ 743 $ 2,518 $ 2,268 Total revenues $ 162,582 $ 121,072 $ 420,364 $ 292,304 _________________ (1) Premiums retained by Direct Agents are recognized as income to the Distribution segment, and expense to the Underwriting segment. Upon consolidation, the impact of these internal segment transactions is eliminated. See Note 7. Segment information for additional breakdown. (2) Interest and investment income consists primarily of interest payments received on held-to-maturity debt securities, available-for-sale debt securities and mortgage loans.

Liability for loss and loss a_2

Liability for loss and loss adjustment expenses (Tables)	9 Months Ended
	Sep. 30, 2021
Insurance [Abstract]
Summary of Liability for Loss and Loss Adjustment Expenses	A summary of the changes in the liability for loss and loss adjustment expenses for the nine months ending September 30, 2021 and 2020 is as follows: September 30, 2021 2020 Balance at the beginning of the year $ 69,800 $ 62,758 Provision for claims related to: Current year $ 23,567 $ 15,761 Prior years (6,826) (5,696) Total provision for claims $ 16,741 $ 10,065 Paid losses related to: Current year $ (2,832) $ (1,636) Prior years (5,038) (5,055) Total paid losses $ (7,870) $ (6,691) Balance at the end of the period $ 78,671 $ 66,132 Provision for claims as a percentage of net written premiums 4.7 % 4.1 %

Segment information (Tables)

Segment information (Tables)	9 Months Ended
	Sep. 30, 2021
Segment Reporting [Abstract]
Summary of Operating Results of the Company's Reportable Segments	The following table summarizes the operating results of the Company’s reportable segments: Three months ended September 30, 2021 Distribution Underwriting Eliminations Consolidated total Net premiums written $ — $ 141,587 $ (96) $ 141,491 Escrow, other title-related fees and other (1) 47,573 823 (27,944) 20,452 Investment, dividend and other income 47 592 — 639 Total revenue $ 47,620 $ 143,002 $ (28,040) $ 162,582 Premiums retained by agents (2) $ — $ 119,636 $ (28,040) $ 91,596 Direct labor (3) 21,791 2,157 — 23,948 Other direct costs (4) 5,650 4,423 — 10,073 Provision for claims 1,243 5,442 — 6,685 Adjusted gross profit $ 18,936 $ 11,344 $ — $ 30,280 Nine months ended September 30, 2021 Distribution Underwriting Eliminations Consolidated total Net premiums written $ — $ 359,730 $ (976) $ 358,754 Escrow, other title-related fees and other (1) 131,506 2,621 (75,035) 59,092 Investment, dividend and other income 130 2,388 — 2,518 Total revenue $ 131,636 $ 364,739 $ (76,011) $ 420,364 Premiums retained by agents (2) $ — $ 303,126 $ (76,011) $ 227,115 Direct labor (3) 56,884 5,945 — 62,829 Other direct costs (4) 16,846 7,896 — 24,742 Provision for claims 1,777 14,964 — 16,741 Adjusted gross profit $ 56,129 $ 32,808 $ — $ 88,937 Three months ended September 30, 2020 Distribution Underwriting Eliminations Consolidated total Net premiums written $ — $ 103,587 $ — $ 103,587 Escrow, other title-related fees and other (1) 36,094 490 (19,842) 16,742 Investment, dividend and other income (40) 783 — 743 Total revenue $ 36,054 $ 104,860 $ (19,842) $ 121,072 Premiums retained by agents (2) $ — $ 86,866 $ (19,842) $ 67,024 Direct labor (3) 13,185 1,707 — 14,892 Other direct costs (4) 4,711 1,603 — 6,314 Provision for claims 617 4,625 — 5,242 Adjusted gross profit $ 17,541 $ 10,059 $ — $ 27,600 Nine months ended September 30, 2020 Distribution Underwriting Eliminations Consolidated total Net premiums written $ — $ 246,738 $ — $ 246,738 Escrow, other title-related fees and other (1) 93,043 1,088 (50,833) 43,298 Investment, dividend and other income 614 1,654 — 2,268 Total revenue $ 93,657 $ 249,480 $ (50,833) $ 292,304 Premiums retained by agents (2) $ — $ 206,965 $ (50,833) $ 156,132 Direct labor (3) 40,213 4,891 — 45,104 Other direct costs (4) 12,433 3,916 — 16,349 Provision for claims 1,006 9,059 — 10,065 Adjusted gross profit $ 40,005 $ 24,649 $ — $ 64,654 _________________ (1) Includes fee income from closings, escrow, title exams, ceding commission income, as well as premiums retained by Direct Agents. (2) This expense represents a deduction from the net premiums written for the amounts that are retained by Direct Agents and Third-Party Agents as compensation for their efforts to generate premium income for our Underwriting segment. The impact of premiums retained by our Direct Agents and the expense for reinsurance or co-insurance procured on Direct Agents sourced premiums are eliminated in consolidation. (3) Includes all compensation costs, including salaries, bonuses, incentive payments, and benefits, for personnel involved in the direct fulfillment of title and/or escrow services. (4) Includes title examination expense, office supplies, and premium and other taxes.
Reconciliation of Company's Total Reportable Segments' Adjusted Gross Profit to Total Loss Before Income Taxes	The following table provides a reconciliation of the Company’s total reportable segments’ adjusted gross profit to its total loss before income taxes: Three months ended September 30, Nine months ended September 30, 2021 2020 2021 2020 Adjusted gross profit $ 30,280 $ 27,600 $ 88,937 $ 64,654 Depreciation and amortization 1,978 1,221 7,705 3,236 Corporate and other expenses (1) 53,393 28,604 133,234 82,910 Change in fair value of Warrant and Sponsor Covered Shares liabilities 4,478 — 4,478 — Interest expense 4,531 1,193 12,341 4,428 Loss before income taxes $ (34,100) $ (3,418) $ (68,821) $ (25,920) _________________ (1) Includes corporate and other costs not allocated to segments including corporate support function costs, such as legal, finance, human resources, technology support and certain other indirect operating expenses, such as sales and management payroll, and incentive related expenses.

Stock compensation expense (Tab

Stock compensation expense (Tables)	9 Months Ended
	Sep. 30, 2021
Share-based Payment Arrangement [Abstract]
Summary of Stock Option Activity	During the nine months ended September 30, 2021, the Company had the following stock option activity (option amounts have been retroactively restated as shares reflecting the Exchange Ratio): Number of Stock Options Weighted Average Exercise Price ($) Weighted Average Remaining Contractual Life (In years) Aggregate Intrinsic Value ($) Outstanding as of December 31, 2020 26,492,158 $ 0.53 8.5 $ 374,808 Granted 4,583,033 0.71 9.25 Exercised (4,004,764) 0.43 7.2 Cancelled or forfeited (786,607) 0.66 8.41 Outstanding as of September 30, 2021 26,283,820 $ 0.58 8.03 $ 179,382 Options exercisable as of September 30, 2021 10,412,664 $ 0.49 7.48 $ 71,902
Summary of Nonvested Restricted Stock Awards	During the nine months ended September 30, 2021, the Company had the following non-vested RSA activity (share amounts have been retroactively restated as shares reflecting the Exchange Ratio): Number of RSAs Average Grant Date Fair Value ($) Non-vested at December 31, 2020 1,551,867 $ 0.52 Granted — — Exercised (613,563) 0.38 Cancelled or Forfeited — — Non-vested at September 30, 2021 938,304 $ 0.61

Earnings per share (Tables)

Earnings per share (Tables)	9 Months Ended
	Sep. 30, 2021
Earnings Per Share [Abstract]
Schedule of Basic and Diluted Earnings Per Share	The calculation of the basic and diluted EPS is as follows: Three months ended September 30, Nine months ended September 30, 2021 2020 2021 2020 Numerator Net loss attributable to Doma Holdings, Inc. $ (34,270) $ (3,622) $ (69,327) $ (26,540) Denominator Weighted-average common shares – basic and diluted 245,003,754 64,060,987 128,105,954 62,255,035 Net loss per share attributable to Doma Holdings, Inc. shareholders Basic and diluted $ (0.14) $ (0.06) $ (0.54) $ (0.43)
Schedule of Antidilutive Securities Excluded from Computation	The following potential outstanding shares of common stock w ere excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been antidilutive: As of September 30, 2021 2020 Convertible preferred stock — 183,159,138 Outstanding stock options 26,283,820 27,621,396 Warrants for common stock 18,022,750 28,870,386 Restricted stock units 938,304 2,083,281 Total antidilutive securities 45,244,874 241,734,201

Commitment and contingencies (T

Commitment and contingencies (Tables)	9 Months Ended
	Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Schedule of Minimum Operating Lease Payments	As of September 30, 2021, total future commitments on non-cancelable operating leases with a minimum remaining term in excess of one year are as follows: 2021 $ 2,311 2022 9,059 2023 8,037 2024 6,417 2025 4,724 Thereafter 7,032 Total $ 37,580

Accrued expenses and other li_2

Accrued expenses and other liabilities (Tables)	9 Months Ended
	Sep. 30, 2021
Payables and Accruals [Abstract]
Schedule of Accrued Expenses and Other Liabilities	Accrued expenses and other liabilities include the following: September 30, December 31, Employee compensation and benefits $ 32,746 $ 23,899 Other 17,441 9,145 Total accrued expenses and other liabilities $ 50,187 $ 33,044

Organization and business ope_2

Organization and business operations (Details)	9 Months Ended
	Sep. 30, 2021segmentstate
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of states operated in | state	39
Number of reportable segments | segment	2

Summary of significant accoun_3

Summary of significant accounting policies - Title Plants (Details) - USD ($)	1 Months Ended	3 Months Ended		9 Months Ended
	Feb. 29, 2020	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Indefinite-lived Intangible Assets [Line Items]
Proceeds from sale of title plant				$ 482,000	$ 1,349,000
Title Plant
Indefinite-lived Intangible Assets [Line Items]
Impairment of title plants		$ 0	$ 0	$ 0	$ 0
Proceeds from sale of title plant	$ 3,200,000
Gain on sale of title plant	$ 200,000

Summary of significant accoun_4

Summary of significant accounting policies - Reinsurance (Details) $ in Millions	Feb. 24, 2021	Feb. 23, 2021	Sep. 30, 2020	Sep. 30, 2021USD ($)treaty	Sep. 30, 2020
Reinsurance Retention Policy [Line Items]
Number of reinsurance treaties | treaty				2
Excess Of Loss Treaty
Reinsurance Retention Policy [Line Items]
Retention limit				$ 15
Maximum amount reinsured				$ 500
Quota Share Treaty
Reinsurance Retention Policy [Line Items]
Reinsured percentage	25.00%	100.00%	100.00%		100.00%

Summary of significant accoun_5

Summary of significant accounting policies - Income Taxes (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Effective tax rate	(1.00%)	(2.00%)
Operating loss carryforwards, subject to expiration	$ 0.2
Accrued Liabilities and Other Liabilities
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Net deferred tax liability	$ 1.2		$ 1

Summary of significant accoun_6

Summary of significant accounting policies - Warrants and Earnout Shares (Details) - $ / shares	Sep. 30, 2021	Dec. 31, 2020
Accounting Policies [Abstract]
Common stock, par value (in usd per share)	$ 0.0001	$ 0.0001

Business Combination (Details)

Business Combination (Details) $ / shares in Units, $ in Thousands	Jul. 28, 2021USD ($)tranche$ / sharesshares	Jul. 27, 2021USD ($)	Sep. 30, 2021USD ($)$ / sharesshares	Sep. 30, 2021USD ($)$ / sharesshares	Sep. 30, 2020USD ($)	Sep. 03, 2021shares	Dec. 31, 2020$ / sharesshares	Dec. 04, 2020$ / sharesshares
Schedule Of Reverse Recapitalization [Line Items]
Cash acquired through reverse recapitalization | $	$ 345,000
Common stock redeemed | $	294,900
Proceeds from business combination | $	$ 20,100			$ 624,952	$ 0
Number of shares issued in transaction (in shares)	30,000,000
Sale price per share (in usd per share) | $ / shares	$ 10
Purchase price | $	$ 300,000
Common stock, par value (in usd per share) | $ / shares			$ 0.0001	$ 0.0001			$ 0.0001
Recapitalization exchange ratio	5.994933
Transaction costs | $	$ 67,000
Payments of transaction costs | $			$ (63,200)
Common stock, shares outstanding (in shares)	321,461,822		321,544,052	321,544,052			62,832,307
Common stock, shares authorized (in shares)			2,000,000,000	2,000,000,000
Preferred stock, shares authorized (in shares)			100,000,000	100,000,000
Preferred stock, par value (in usd per share) | $ / shares			$ 0.0001	$ 0.0001
Common stock, shares issued (in shares)			321,544,052	321,544,052			62,832,307
Preferred stock, shares issued (in shares)			0	0
Preferred stock, shares outstanding (in shares)			0	0
Number of warrants (in shares)						17,333,333
Capitol
Schedule Of Reverse Recapitalization [Line Items]
Transaction costs | $		$ 12,100
Public Warrants
Schedule Of Reverse Recapitalization [Line Items]
Number of warrants (in shares)			11,500,000	11,500,000				11,500,000
Exercise price of warrants (in usd per share) | $ / shares								$ 11.50
Private Placement Warrants
Schedule Of Reverse Recapitalization [Line Items]
Number of warrants (in shares)			5,833,333	5,833,333				5,833,333
Exercise price of warrants (in usd per share) | $ / shares								$ 11.50
Sponsor Covered Shares
Schedule Of Reverse Recapitalization [Line Items]
Common stock, shares outstanding (in shares)	13,256.64
Percentage of shares subject to vesting	20.00%
Number of vesting tranches | tranche	2
Period threshold for change in control	10 years
Sponsor Covered Shares | Sale price of common stock equals or exceeds $15
Schedule Of Reverse Recapitalization [Line Items]
Percentage of vesting shares	50.00%
Stock price trigger (in usd per share) | $ / shares	$ 15
Trading days threshold	20 days
Consecutive trading days threshold	30 days
Sponsor Covered Shares | Sale price of common stock equals or exceeds $17.50
Schedule Of Reverse Recapitalization [Line Items]
Percentage of vesting shares	50.00%
Stock price trigger (in usd per share) | $ / shares	$ 17.50
Trading days threshold	20 days
Consecutive trading days threshold	30 days
Earnout Shares
Schedule Of Reverse Recapitalization [Line Items]
Number of vesting tranches | tranche	2
Additional shares receivable	5.00%
Earnout Shares | Sale price of common stock equals or exceeds $15
Schedule Of Reverse Recapitalization [Line Items]
Percentage of vesting shares	50.00%
Stock price trigger (in usd per share) | $ / shares	$ 15
Trading days threshold	20 days
Consecutive trading days threshold	30 days
Earnout Shares | Sale price of common stock equals or exceeds $17.50
Schedule Of Reverse Recapitalization [Line Items]
Percentage of vesting shares	50.00%
Stock price trigger (in usd per share) | $ / shares	$ 17.50
Trading days threshold	20 days
Consecutive trading days threshold	30 days

Investments and fair value me_3

Investments and fair value measurements - Summary of Held-to-Maturity Debt Securities (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	$ 74,872	$ 65,406
Unrealized Gains	769	1,048
Unrealized Losses	(44)	(53)
Fair Value	75,597	66,401
Corporate debt securities
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	69,670	57,651
Unrealized Gains	766	994
Unrealized Losses	(43)	(53)
Fair Value	70,393	58,592
U.S. Treasury securities
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	4,965	7,519
Unrealized Gains	3	54
Unrealized Losses	(1)	0
Fair Value	4,967	7,573
Certificates of deposit
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	237	236
Unrealized Gains	0	0
Unrealized Losses	0	0
Fair Value	$ 237	$ 236

Investments and fair value me_4

Investments and fair value measurements - Narrative (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Investments, All Other Investments [Abstract]
Debt securities, held-to-maturity, restricted	$ 4,600,000		$ 4,600,000		$ 5,100,000
Change in net unrealized gains (losses) on held-to-maturity debt			(300,000)	$ 700,000
Change in net unrealized gains on available-for-sale debt securities	0	$ 600,000	(900,000)	$ (100,000)
Unrealized Gains	0		0		918,000
Unrealized losses	$ 0		$ 0		$ 0

Investments and fair value me_5

Investments and fair value measurements - Summary of Realized Gains (Losses) on Held-to-Maturity Debt Securities (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Held-to-maturity debt securities:
Gains	$ 0	$ 0	$ 65	$ 15
Losses	0	0	(11)	0
Net	0	0	54	15
Proceeds from sales	$ 0	$ 0	$ 3,048	$ 1,504

Investments and fair value me_6

Investments and fair value measurements - Summary of Held-to-Maturity Debt Securities Maturity (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Amortized Cost
One year or less	$ 24,951
After one year through five years	49,921
Amortized Cost	$ 74,872	$ 65,406
Amortized Cost, Percent of Total
One year or less	33.00%
After one year through five years	67.00%
Total	100.00%
Fair Value
One year or less	$ 25,103
After one year through five years	50,494
Fair Value	$ 75,597	$ 66,401
Fair Value, Percent of Total
One year or less	33.00%
After one year through five years	67.00%
Total	100.00%

Investments and fair value me_7

Investments and fair value measurements - Schedule of Unrealized Loss on Held-to-Maturity Debt Securities (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Schedule of Held-to-maturity Securities [Line Items]
HTM, Less than 12 months, Fair value	$ 7,610	$ 13,645
HTM, Less than 12 months, Unrealized losses	(39)	(53)
HTM, Greater than 12 months, Fair value	151	0
HTM, Greater than 12 months, Unrealized losses	(5)	0
HTM, Fair value	7,761	13,645
HTM, Unrealized losses	(44)	(53)
Corporate debt securities
Schedule of Held-to-maturity Securities [Line Items]
HTM, Less than 12 months, Fair value	5,934	8,464
HTM, Less than 12 months, Unrealized losses	(38)	(53)
HTM, Greater than 12 months, Fair value	151	0
HTM, Greater than 12 months, Unrealized losses	(5)	0
HTM, Fair value	6,085	8,464
HTM, Unrealized losses	(43)	(53)
U.S. Treasury securities
Schedule of Held-to-maturity Securities [Line Items]
HTM, Less than 12 months, Fair value	1,676	5,181
HTM, Less than 12 months, Unrealized losses	(1)	0
HTM, Greater than 12 months, Fair value	0	0
HTM, Greater than 12 months, Unrealized losses	0	0
HTM, Fair value	1,676	5,181
HTM, Unrealized losses	(1)	0
Certificates of deposit
Schedule of Held-to-maturity Securities [Line Items]
HTM, Less than 12 months, Fair value	0	0
HTM, Less than 12 months, Unrealized losses	0	0
HTM, Greater than 12 months, Fair value	0	0
HTM, Greater than 12 months, Unrealized losses	0	0
HTM, Fair value	0	0
HTM, Unrealized losses	$ 0	$ 0

Investments and fair value me_8

Investments and fair value measurements -Summary of Available-for-Sale Debt Securities (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Debt Securities, Available-for-sale [Line Items]
Cost Basis		$ 7,139,000
Unrealized Gains	$ 0	918,000
Unrealized Losses	0	0
Fair Value	$ 0	8,057,000
Corporate debt securities
Debt Securities, Available-for-sale [Line Items]
Cost Basis		7,139,000
Unrealized Gains		918,000
Unrealized Losses		0
Fair Value		$ 8,057,000

Investments and fair value me_9

Investments and fair value measurements - Summary of Realized Gains (Losses) on Available-for-Sale Debt Securities (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Available-for-sale debt securities:
Gains	$ 0	$ 0	$ 768	$ 0
Losses	0	0	(90)	0
Net	0	0	678	0
Proceeds from sales	$ 0	$ 0	$ 7,817	$ 0

Investments and fair value m_10

Investments and fair value measurements - Summary of Equity Securities (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Debt and Equity Securities, FV-NI [Line Items]
Cost	$ 0	$ 2,000
Estimated Fair Value	0	2,119
Preferred Stock
Debt and Equity Securities, FV-NI [Line Items]
Cost	0	2,000
Estimated Fair Value	$ 0	$ 2,119

Investments and fair value m_11

Investments and fair value measurements - Summary of Mortgage Loans (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Net Investment Income [Line Items]
Mortgage loans	$ 2,920	$ 2,980
Cost
Net Investment Income [Line Items]
Mortgage loans	2,920	2,980
Estimated Fair Value
Net Investment Income [Line Items]
Mortgage loans	$ 2,920	$ 2,980

Investments and fair value m_12

Investments and fair value measurements - Schedule of Investment Income (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Net Investment Income [Line Items]
Interest and investment income	$ 588	$ 783	$ 2,388	$ 1,655
Available-for-sale debt securities
Net Investment Income [Line Items]
Interest and investment income	0	102	773	306
Held-to-maturity debt securities
Net Investment Income [Line Items]
Interest and investment income	543	465	1,507	987
Equity investments
Net Investment Income [Line Items]
Interest and investment income	0	166	(89)	56
Mortgage loans
Net Investment Income [Line Items]
Interest and investment income	45	46	136	149
Other
Net Investment Income [Line Items]
Interest and investment income	$ 0	$ 4	$ 61	$ 157

Investments and fair value m_13

Investments and fair value measurements - Summary of Accrued Interest (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Debt and Equity Securities, FV-NI [Line Items]
Accrued interest receivable on investments	$ 627	$ 729
Debt Securities
Debt and Equity Securities, FV-NI [Line Items]
Accrued interest receivable on investments	606	686
Corporate debt securities
Debt and Equity Securities, FV-NI [Line Items]
Accrued interest receivable on investments	568	641
U.S. Treasury securities
Debt and Equity Securities, FV-NI [Line Items]
Accrued interest receivable on investments	38	45
Mortgage loans
Debt and Equity Securities, FV-NI [Line Items]
Accrued interest receivable on investments	$ 21	$ 43

Investments and fair value m_14

Investments and fair value measurements - Summary of Company's Investments Measured at Fair Value (Details) - Fair Value, Recurring - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	$ 78,517	$ 79,557
Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	70,393	66,649
U.S. Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	4,967	7,573
Mortgage loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	2,920	2,980
Preferred Stock
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	0	2,119
Certificates of deposit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	237	236
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	4,967	9,692
Level 1 | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	0	0
Level 1 | U.S. Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	4,967	7,573
Level 1 | Mortgage loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	0	0
Level 1 | Preferred Stock
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	0	2,119
Level 1 | Certificates of deposit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	0	0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	70,630	66,885
Level 2 | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	70,393	66,649
Level 2 | U.S. Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	0	0
Level 2 | Mortgage loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	0	0
Level 2 | Preferred Stock
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	0	0
Level 2 | Certificates of deposit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	237	236
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	2,920	2,980
Level 3 | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	0	0
Level 3 | U.S. Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	0	0
Level 3 | Mortgage loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	2,920	2,980
Level 3 | Preferred Stock
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	0	0
Level 3 | Certificates of deposit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments	$ 0	$ 0

Investments and fair value m_15

Investments and fair value measurements - Summary of Company's Liabilities Measured at Fair Value (Details) - Fair Value, Recurring - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	$ 33,050	$ 0
Public Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	16,215	0
Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	8,225	0
Sponsor Covered Shares
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	8,610	0
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	16,215	0
Level 1 | Public Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	16,215	0
Level 1 | Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	0	0
Level 1 | Sponsor Covered Shares
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	0	0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	8,225	0
Level 2 | Public Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	0	0
Level 2 | Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	8,225	0
Level 2 | Sponsor Covered Shares
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	0	0
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	8,610	0
Level 3 | Public Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	0	0
Level 3 | Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	0	0
Level 3 | Sponsor Covered Shares
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	$ 8,610	$ 0

Investments and fair value m_16

Investments and fair value measurements - Summary of Fair Values of the Sponsor Earnout Shares Using a Monte Carlo Simulation Valuation Model (Details) - Sponsor Covered Shares	Sep. 30, 2021$ / shares
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Share price (in usd per share)	$ 7.40
Vesting Period
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative, measurement input	10
Expected volatility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative, measurement input	0.552
Risk-free interest rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative, measurement input	0.0150
Expected term
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative, measurement input	9.83
Expected dividend yield
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative, measurement input	0
Annual change in control probability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative, measurement input	0.020

Investments and fair value m_17

Investments and fair value measurements - Changes for Level 3 Items Measured at Fair Value (Details) $ in Thousands	3 Months Ended
	Sep. 30, 2021USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value as of June 30, 2021	$ 0
Sponsor Covered Shares assumed in Business Combination	9,332
Change in fair value of Sponsor Covered Shares	(722)
Fair value as of September 30, 2021	$ 8,610

Revenue recognition (Details)

Revenue recognition (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Disaggregation of Revenue [Line Items]
Net premiums written	[1]	$ 141,491	$ 103,587	$ 358,754	$ 246,738
Escrow, title-related and other fees		20,452	16,742	59,092	43,298
Total other revenues		639	743	2,518	2,268
Total revenues		162,582	121,072	420,364	292,304
Eliminations
Disaggregation of Revenue [Line Items]
Net premiums written		(96)	0	(976)	0
Escrow, title-related and other fees		(27,944)	(19,842)	(75,035)	(50,833)
Total other revenues		0	0	0	0
Total revenues		(28,040)	(19,842)	(76,011)	(50,833)
Underwriting | Operating Segments
Disaggregation of Revenue [Line Items]
Net premiums written		141,587	103,587	359,730	246,738
Escrow, title-related and other fees		823	490	2,621	1,088
Interest and investment income		493	659	1,483	1,513
Realized gains and losses, net		99	124	905	141
Total other revenues		592	783	2,388	1,654
Total revenues		143,002	104,860	364,739	249,480
Distribution | Operating Segments
Disaggregation of Revenue [Line Items]
Net premiums written		0	0	0	0
Escrow, title-related and other fees		47,573	36,094	131,506	93,043
Interest and investment income		68	33	155	304
Realized gains and losses, net		(21)	(73)	(25)	310
Total other revenues		47	(40)	130	614
Total revenues		47,620	36,054	131,636	93,657
Direct Agents title insurance premiums | Eliminations
Disaggregation of Revenue [Line Items]
Net premiums written		(96)	0	(976)	0
Direct Agents title insurance premiums | Underwriting | Operating Segments
Disaggregation of Revenue [Line Items]
Net premiums written		32,944	23,146	88,797	59,399
Third-Party Agents title insurance premiums | Underwriting | Operating Segments
Disaggregation of Revenue [Line Items]
Net premiums written		108,643	80,441	270,933	187,339
Escrow Fees | Distribution | Operating Segments
Disaggregation of Revenue [Line Items]
Escrow, title-related and other fees		16,190	11,456	45,325	29,331
Other Title Fees | Eliminations
Disaggregation of Revenue [Line Items]
Escrow, title-related and other fees		(27,944)	(19,842)	(75,035)	(50,833)
Other Title Fees | Underwriting | Operating Segments
Disaggregation of Revenue [Line Items]
Escrow, title-related and other fees		823	490	2,621	1,088
Other Title Fees | Distribution | Operating Segments
Disaggregation of Revenue [Line Items]
Escrow, title-related and other fees		$ 31,383	$ 24,638	$ 86,181	$ 63,712
[1]	Net premiums written includes revenues from a related party of $30.3 million and $22.9 million during the three months ended September 30, 2021 and 2020, respectively. Net premiums written includes revenues from a related party of $81.9 million and $64.2 million during the nine months ended September 30, 2021 and 2020, respectively (see Note 11).

Liability for loss and loss a_3

Liability for loss and loss adjustment expenses - Summary of Liability for Loss and Loss Adjustment Expenses (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]
Balance at the beginning of the year			$ 69,800	$ 62,758
Provision for claims related to:
Current year			23,567	15,761
Prior years			(6,826)	(5,696)
Total provision for claims	$ 6,685	$ 5,242	16,741	10,065
Paid losses related to:
Current year			(2,832)	(1,636)
Prior years			(5,038)	(5,055)
Total paid losses			(7,870)	(6,691)
Balance at the end of the period	$ 78,671	$ 66,132	$ 78,671	$ 66,132
Premiums Written, Net | Provision for Incurred Claims Concentration Risk | Liability for Unpaid Claims and Claims Adjustment Expense, Net
Paid losses related to:
Concentration risk percent			4.70%	4.10%

Liability for loss and loss a_4

Liability for loss and loss adjustment expenses - Narrative (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	Dec. 31, 2019
Insurance [Abstract]
Prior year reserve release	$ 6,826	$ 5,696
Liability for loss and loss adjustment expenses	78,671	$ 66,132	$ 69,800	$ 62,758
Reserves for settlement related to escrow or agent activities	$ 200		$ 700

Segment information - Narrative

Segment information - Narrative (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2021USD ($)branchstate	Dec. 31, 2020USD ($)
Segment Reporting Information [Line Items]
Number of states operated in | state	39
Goodwill	$ 111,487	$ 111,487
Distribution
Segment Reporting Information [Line Items]
Number of branches | branch	94
Number of states operated in | state	10
Goodwill	$ 88,100	88,100
Underwriting
Segment Reporting Information [Line Items]
Premium percentage retained	84.00%
Goodwill	$ 23,400	$ 23,400

Segment information - Summary o

Segment information - Summary of Operating Results by Segment (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Segment Reporting Information [Line Items]
Net premiums written	[1]	$ 141,491	$ 103,587	$ 358,754	$ 246,738
Escrow, other title-related fees and other		20,452	16,742	59,092	43,298
Investment, dividend and other income		639	743	2,518	2,268
Total revenues		162,582	121,072	420,364	292,304
Premiums retained by agents	[2]	91,596	67,024	227,115	156,132
Direct labor		23,948	14,892	62,829	45,104
Other direct costs		10,073	6,314	24,742	16,349
Provision for claims		6,685	5,242	16,741	10,065
Adjusted gross profit		30,280	27,600	88,937	64,654
Operating Segments | Distribution
Segment Reporting Information [Line Items]
Net premiums written		0	0	0	0
Escrow, other title-related fees and other		47,573	36,094	131,506	93,043
Investment, dividend and other income		47	(40)	130	614
Total revenues		47,620	36,054	131,636	93,657
Premiums retained by agents		0	0	0	0
Direct labor		21,791	13,185	56,884	40,213
Other direct costs		5,650	4,711	16,846	12,433
Provision for claims		1,243	617	1,777	1,006
Adjusted gross profit		18,936	17,541	56,129	40,005
Operating Segments | Underwriting
Segment Reporting Information [Line Items]
Net premiums written		141,587	103,587	359,730	246,738
Escrow, other title-related fees and other		823	490	2,621	1,088
Investment, dividend and other income		592	783	2,388	1,654
Total revenues		143,002	104,860	364,739	249,480
Premiums retained by agents		119,636	86,866	303,126	206,965
Direct labor		2,157	1,707	5,945	4,891
Other direct costs		4,423	1,603	7,896	3,916
Provision for claims		5,442	4,625	14,964	9,059
Adjusted gross profit		11,344	10,059	32,808	24,649
Eliminations
Segment Reporting Information [Line Items]
Net premiums written		(96)	0	(976)	0
Escrow, other title-related fees and other		(27,944)	(19,842)	(75,035)	(50,833)
Investment, dividend and other income		0	0	0	0
Total revenues		(28,040)	(19,842)	(76,011)	(50,833)
Premiums retained by agents		(28,040)	(19,842)	(76,011)	(50,833)
Direct labor		0	0	0	0
Other direct costs		0	0	0	0
Provision for claims		0	0	0	0
Adjusted gross profit		$ 0	$ 0	$ 0	$ 0
[1]	Net premiums written includes revenues from a related party of $30.3 million and $22.9 million during the three months ended September 30, 2021 and 2020, respectively. Net premiums written includes revenues from a related party of $81.9 million and $64.2 million during the nine months ended September 30, 2021 and 2020, respectively (see Note 11).
[2]	Premiums retained by Third-Party Agents includes expenses associated with a related party of $24.8 million and $18.4 million during the three months ended September 30, 2021 and 2020, respectively. Premiums retained by Third-Party Agents includes expenses associated with a related party of $66.6 million and $51.9 million during the nine months ended September 30, 2021 and 2020, respectively (see Note 11).

Segment information - Reconcili

Segment information - Reconciliation of Adjusted Gross Profit to Loss Before Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Segment Reporting [Abstract]
Adjusted gross profit	$ 30,280	$ 27,600	$ 88,937	$ 64,654
Depreciation and amortization	1,978	1,221	7,705	3,236
Other operating expenses	53,393	28,604	133,234	82,910
Change in fair value of Warrant and Sponsor Covered Shares liabilities	4,478	0	4,478	0
Interest expense	4,531	1,193	12,341	4,428
Loss before income taxes	$ (34,100)	$ (3,418)	$ (68,821)	$ (25,920)

Debt (Details)

Debt (Details) - USD ($)	Jan. 29, 2021	Dec. 31, 2020	Sep. 30, 2021	Sep. 03, 2021	Jan. 07, 2019
Debt Instrument [Line Items]
Number of warrants (in shares)				17,333,333
Loan from a related party		$ 65,532,000	$ 0
Penny Warrant
Debt Instrument [Line Items]
Percentage of shares called by each warrant	1.35%
Number of warrants (in shares)		4,200,000
Notes Payable, Related Party
Debt Instrument [Line Items]
Debt instrument, face amount					$ 87,000,000
Senior Debt | Senior Notes
Debt Instrument [Line Items]
Debt instrument, face amount		$ 150,000,000
Proceeds from debt	$ 150,000,000
Debt instrument, term		5 years
Debt instrument, stated interest rate		11.25%
Debt instrument, percentage of interest paid in cash		5.00%
Debt instrument, debt default interest rate		15.00%
Minimum liquidity covenant		$ 20,000,000
Minimum consolidated revenue covenant		$ 130,000,000
Period for monthly payments		24 months

Stock compensation expense - Na

Stock compensation expense - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock based compensation expense	$ 3	$ 0.4	$ 9	$ 0.9
Outstanding stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expiration period			10 years
Outstanding stock options | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period			7 months
Outstanding stock options | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period			60 months

Stock compensation expense - Su

Stock compensation expense - Summary of Stock Options (Details) $ / shares in Units, $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2021USD ($)$ / sharesshares	Dec. 31, 2020USD ($)$ / sharesshares
Number of Stock Options
Beginning balance outstanding (in shares) | shares	26,492,158
Granted (in shares) | shares	4,583,033
Exercised (in shares) | shares	(4,004,764)
Cancelled or forfeited (in shares) | shares	(786,607)
Ending balance outstanding (in shares) | shares	26,283,820	26,492,158
Options exercisable, Number of Stock Options (in shares) | shares	10,412,664
Weighted Average Exercise Price ($)
Beginning balance outstanding (in usd per share) | $ / shares	$ 0.53
Granted (in usd per share) | $ / shares	0.71
Exercised (in usd per share) | $ / shares	0.43
Cancelled or forfeited (in usd per share) | $ / shares	0.66
Ending balance outstanding (in usd per share) | $ / shares	0.58	$ 0.53
Options exercisable, Weighted Average Exercise Price (in usd per share) | $ / shares	$ 0.49
Stock Option Activity, Additional Disclosures
Outstanding balance, Weighted Average Remaining Contractual Life	8 years 10 days	8 years 6 months
Granted, Weighted Average Remaining Contractual Life	9 years 3 months
Exercised, Weighted Average Remaining Contractual Life	7 years 2 months 12 days
Cancelled or forfeited, Weighted Average Remaining Contractual Life	8 years 4 months 28 days
Options Exercisable, Weighted Average Remaining Contractual Life	7 years 5 months 23 days
Beginning balance outstanding, Aggregate Intrinsic Value | $	$ 374,808
Ending balance outstanding, Aggregate Intrinsic Value | $	179,382	$ 374,808
Options exercisable, Aggregate Intrinsic Value | $	$ 71,902

Stock compensation expense - No

Stock compensation expense - Nonvested Restricted Stock Awards (Details) - Restricted Stock	9 Months Ended
	Sep. 30, 2021$ / sharesshares
Number of RSAs
Beginning balance non-vested (in shares) | shares	1,551,867
Granted (in shares) | shares	0
Exercised (in shares) | shares	(613,563)
Cancelled or Forfeited (in shares) | shares	0
Ending balance non-vested (in shares) | shares	938,304
Average Grant Date Fair Value ($)
Beginning balance non-vested (in usd per share) | $ / shares	$ 0.52
Granted (in usd per share) | $ / shares	0
Exercised (in usd per share) | $ / shares	0.38
Cancelled or Forfeited (in usd per share) | $ / shares	0
Ending balance non-vested (in usd per share) | $ / shares	$ 0.61

Earnings per share (Details)

Earnings per share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2021	Sep. 30, 2020
Numerator
Net loss attributable to Doma Holdings, Inc.	$ (34,270)	$ (23,299)	$ (11,758)	$ (3,622)	$ (6,332)	$ (16,586)	$ (69,327)	$ (26,540)
Denominator
Weighted-average common shares - basic (in shares)	245,003,754			64,060,987			128,105,954	62,255,035
Weighted-average common shares - diluted (in shares)	245,003,754			64,060,987			128,105,954	62,255,035
Net loss per share attributable to Doma Holdings, Inc. shareholders
Basic (in usd per share)	$ (0.14)			$ (0.06)			$ (0.54)	$ (0.43)
Diluted (in usd per share)	$ (0.14)			$ (0.06)			$ (0.54)	$ (0.43)

Earnings per share - Antidiluti

Earnings per share - Antidilutive Securities Excluded from Computation (Details) - shares	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded (in shares)	45,244,874	241,734,201
Convertible preferred stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded (in shares)	0	183,159,138
Outstanding stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded (in shares)	26,283,820	27,621,396
Warrants for common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded (in shares)	18,022,750	28,870,386
Restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded (in shares)	938,304	2,083,281

Related party transactions (Det

Related party transactions (Details) - USD ($)		3 Months Ended		9 Months Ended
		Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Related Party Transaction [Line Items]
Net premiums written	[1]	$ 141,491,000	$ 103,587,000	$ 358,754,000	$ 246,738,000
Premiums retained by agents	[2]	91,596,000	67,024,000	227,115,000	156,132,000
Receivables		$ 14,485,000		$ 14,485,000		$ 15,244,000
Lennar | Doma Holding, Inc
Related Party Transaction [Line Items]
Equity ownership		25.60%		25.60%
Affiliated Entity | Lennar
Related Party Transaction [Line Items]
Net premiums written		$ 30,300,000	22,900,000	$ 81,900,000	64,200,000
Premiums retained by agents		24,800,000	18,400,000	66,600,000	51,900,000
Receivables		3,400,000		3,400,000		$ 4,400,000
Affiliated Entity | Settlement of TSA Services Arrangement | Lennar
Related Party Transaction [Line Items]
Expenses from transactions with related party			0		300,000
Affiliated Entity | Rent associated with shared spaces | Lennar
Related Party Transaction [Line Items]
Expenses from transactions with related party				100,000	200,000
Affiliated Entity | Consulting Agreement | Keystone Strategy, LLC
Related Party Transaction [Line Items]
Expenses from transactions with related party		300,000	$ 0	300,000	$ 0
Accounts payable, related parties		$ 300,000		$ 300,000
[1]	Net premiums written includes revenues from a related party of $30.3 million and $22.9 million during the three months ended September 30, 2021 and 2020, respectively. Net premiums written includes revenues from a related party of $81.9 million and $64.2 million during the nine months ended September 30, 2021 and 2020, respectively (see Note 11).
[2]	Premiums retained by Third-Party Agents includes expenses associated with a related party of $24.8 million and $18.4 million during the three months ended September 30, 2021 and 2020, respectively. Premiums retained by Third-Party Agents includes expenses associated with a related party of $66.6 million and $51.9 million during the nine months ended September 30, 2021 and 2020, respectively (see Note 11).

Commitment and contingencies -

Commitment and contingencies - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Loss Contingencies [Line Items]
Operating leases, rent expense	$ 2.4	$ 2.4	$ 7	$ 7.5
Escrow Deposit, Contingent Liability
Loss Contingencies [Line Items]
Contingent liabilities	$ 511.1		$ 511.1		$ 290.9

Commitment and contingencies _2

Commitment and contingencies - Schedule of Minimum Operating Lease Payments (Details) $ in Thousands	Sep. 30, 2021USD ($)
Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]
2021	$ 2,311
2022	9,059
2023	8,037
2024	6,417
2025	4,724
Thereafter	7,032
Future minimum lease payments	$ 37,580

Accrued expenses and other li_3

Accrued expenses and other liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Payables and Accruals [Abstract]
Employee compensation and benefits	$ 32,746	$ 23,899
Other	17,441	9,145
Total accrued expenses and other liabilities	$ 50,187	$ 33,044

Employee benefit plan (Details)

Employee benefit plan (Details) - USD ($)	3 Months Ended	4 Months Ended	8 Months Ended	9 Months Ended
	Sep. 30, 2021	May 15, 2020	Dec. 31, 2020	Sep. 30, 2021	Sep. 30, 2020
Retirement Benefits [Abstract]
Employer matching contribution percentage				50.00%
Employer matching percentage of employee's gross pay				6.00%
Maximum annual contributions per employee that receive an employer match, percent				3.00%
Defined contributions	$ 700,000	$ 900,000	$ 0	$ 2,000,000	$ 900,000

Research and development (Detai

Research and development (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Research and Development [Abstract]
Research and development expense	$ 5.4	$ 1.7	$ 10.8	$ 4.5
Capitalized internally developed software in period	5.3	3.1	14.2	8.3
Research and development spend	$ 10.7	$ 4.8	$ 25	$ 12.8

Warrant liabilities (Details)

Warrant liabilities (Details) $ / shares in Units, $ in Thousands	Jul. 28, 2021$ / shares	Sep. 30, 2021USD ($)shares	Sep. 03, 2021shares	Dec. 31, 2020USD ($)	Dec. 04, 2020$ / sharesshares
Class of Warrant or Right [Line Items]
Number of warrants (in shares) | shares			17,333,333
Warrant, term	1 year
Warrant liabilities | $		$ 24,440		$ 0
Public Warrants
Class of Warrant or Right [Line Items]
Number of warrants (in shares) | shares		11,500,000			11,500,000
Exercise price of warrants (in usd per share)					$ 11.50
Redemption period	30 days
Fair market value price period	10 days
Fair market value, maximum conversion ratio	0.361
Warrant liabilities | $		$ 16,200
Private Placement Warrants
Class of Warrant or Right [Line Items]
Number of warrants (in shares) | shares		5,833,333			5,833,333
Exercise price of warrants (in usd per share)					$ 11.50
Warrant liabilities | $		$ 8,200
Common stock equals or exceeds $18 | Public Warrants
Class of Warrant or Right [Line Items]
Stock price redemption threshold (in usd per share)	$ 18
Redemption price (in usd per share)	$ 0.01
Notice required for redemption of warrants	30 days
Trading days threshold for warrant redemption	20 days
Consecutive trading days threshold for redemption	30 days
Common stock equals or exceeds $10 | Public Warrants
Class of Warrant or Right [Line Items]
Stock price redemption threshold (in usd per share)	$ 10
Redemption price (in usd per share)	$ 0.10
Notice required for redemption of warrants	30 days
Common stock equals or exceeds $10 | Minimum | Public Warrants
Class of Warrant or Right [Line Items]
Stock price redemption threshold (in usd per share)	$ 10
Common stock equals or exceeds $10 | Maximum | Public Warrants
Class of Warrant or Right [Line Items]
Stock price redemption threshold (in usd per share)	$ 18

Subsequent events (Details)

Subsequent events (Details) - shares	Oct. 05, 2021	Sep. 30, 2021
Restricted Stock
Subsequent Event [Line Items]
Granted (in shares)		0
Subsequent Event | Restricted Stock
Subsequent Event [Line Items]
Granted (in shares)	10,100,000
Subsequent Event | Restricted Stock | Anniversary One
Subsequent Event [Line Items]
Vesting percentage	25.00%
Subsequent Event | Restricted Stock | Anniversary Two
Subsequent Event [Line Items]
Vesting percentage	25.00%
Subsequent Event | Restricted Stock | Anniversary Three
Subsequent Event [Line Items]
Vesting percentage	25.00%
Subsequent Event | Restricted Stock | Anniversary Four
Subsequent Event [Line Items]
Vesting percentage	25.00%
Subsequent Event | Performance Shares
Subsequent Event [Line Items]
Granted (in shares)	3,600,000